[日本語] English
文献
- EMDB/PDB/SASBDBから引用されている文献のデータベース -

+
検索条件

キーワード
構造解析手法
著者・登録者
ジャーナル
IF

-
Structure paper

タイトルPanDDA analysis group deposition
ジャーナル・号・ページTo Be Published
掲載日2017年5月15日 (構造データの登録日)
著者Krojer, T. / Talon, R. / Fairhead, M. / Diaz Saez, L. / Bradley, A.R. / Aimon, A. / Collins, P. / Brandao-Neto, J. / Douangamath, A. / Ruda, G.F. ...Krojer, T. / Talon, R. / Fairhead, M. / Diaz Saez, L. / Bradley, A.R. / Aimon, A. / Collins, P. / Brandao-Neto, J. / Douangamath, A. / Ruda, G.F. / Szommer, T. / Srikannathasan, V. / Elkins, J. / Spencer, J. / London, N. / Nelson, A. / Brennan, P.E. / Huber, K. / Bountra, C. / Arrowsmith, C.H. / Edwards, A. / von Delft, F.
リンクPubMedで検索
手法X線回折
解像度1.05 - 3.28 Å
構造データ

PDB-5q1j:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMSOA000341b
手法: X-RAY DIFFRACTION / 解像度: 1.42 Å

PDB-5q1k:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000074a
手法: X-RAY DIFFRACTION / 解像度: 1.42 Å

PDB-5q1l:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000073a
手法: X-RAY DIFFRACTION / 解像度: 1.76 Å

PDB-5q1m:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000740a
手法: X-RAY DIFFRACTION / 解像度: 1.56 Å

PDB-5q1n:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000295a
手法: X-RAY DIFFRACTION / 解像度: 1.38 Å

PDB-5q1o:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000478a
手法: X-RAY DIFFRACTION / 解像度: 1.25 Å

PDB-5q1p:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000299a
手法: X-RAY DIFFRACTION / 解像度: 1.56 Å

PDB-5q1q:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000294a
手法: X-RAY DIFFRACTION / 解像度: 1.44 Å

PDB-5q1r:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000291a
手法: X-RAY DIFFRACTION / 解像度: 1.49 Å

PDB-5q1s:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with BDOOA011525c
手法: X-RAY DIFFRACTION / 解像度: 1.62 Å

PDB-5q1t:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000492a
手法: X-RAY DIFFRACTION / 解像度: 1.49 Å

PDB-5q1u:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000351a
手法: X-RAY DIFFRACTION / 解像度: 1.5 Å

PDB-5q1v:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000166a
手法: X-RAY DIFFRACTION / 解像度: 1.57 Å

PDB-5q1w:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000546a
手法: X-RAY DIFFRACTION / 解像度: 1.68 Å

PDB-5q1x:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000085a
手法: X-RAY DIFFRACTION / 解像度: 1.42 Å

PDB-5q1y:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000032a
手法: X-RAY DIFFRACTION / 解像度: 1.42 Å

PDB-5q1z:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000150a
手法: X-RAY DIFFRACTION / 解像度: 1.41 Å

PDB-5q20:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000524a
手法: X-RAY DIFFRACTION / 解像度: 1.76 Å

PDB-5q22:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000728a
手法: X-RAY DIFFRACTION / 解像度: 1.18 Å

PDB-5q23:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000543a
手法: X-RAY DIFFRACTION / 解像度: 1.32 Å

PDB-5q24:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000676a
手法: X-RAY DIFFRACTION / 解像度: 1.35 Å

PDB-5q25:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000532a
手法: X-RAY DIFFRACTION / 解像度: 1.43 Å

PDB-5q26:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000710a
手法: X-RAY DIFFRACTION / 解像度: 1.66 Å

PDB-5q27:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000421a
手法: X-RAY DIFFRACTION / 解像度: 1.83 Å

PDB-5q28:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000186a
手法: X-RAY DIFFRACTION / 解像度: 1.52 Å

PDB-5q29:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000058a
手法: X-RAY DIFFRACTION / 解像度: 1.46 Å

PDB-5q2a:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 1)
手法: X-RAY DIFFRACTION / 解像度: 1.5 Å

PDB-5q2b:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 3)
手法: X-RAY DIFFRACTION / 解像度: 1.33 Å

PDB-5q2c:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 4)
手法: X-RAY DIFFRACTION / 解像度: 1.53 Å

PDB-5q2d:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 5)
手法: X-RAY DIFFRACTION / 解像度: 1.4 Å

PDB-5q2e:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 6)
手法: X-RAY DIFFRACTION / 解像度: 1.5 Å

PDB-5q2f:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 7)
手法: X-RAY DIFFRACTION / 解像度: 1.47 Å

PDB-5q2g:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 8)
手法: X-RAY DIFFRACTION / 解像度: 1.49 Å

PDB-5q2h:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 9)
手法: X-RAY DIFFRACTION / 解像度: 1.72 Å

PDB-5q2i:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 10)
手法: X-RAY DIFFRACTION / 解像度: 2.33 Å

PDB-5q2j:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 11)
手法: X-RAY DIFFRACTION / 解像度: 1.3 Å

PDB-5q2k:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 12)
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5q2l:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 13)
手法: X-RAY DIFFRACTION / 解像度: 1.42 Å

PDB-5q2m:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 14)
手法: X-RAY DIFFRACTION / 解像度: 1.28 Å

PDB-5q2n:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 15)
手法: X-RAY DIFFRACTION / 解像度: 1.38 Å

PDB-5q2o:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 16)
手法: X-RAY DIFFRACTION / 解像度: 1.75 Å

PDB-5q2p:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 17)
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5q2q:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 18)
手法: X-RAY DIFFRACTION / 解像度: 1.44 Å

PDB-5q2r:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 19)
手法: X-RAY DIFFRACTION / 解像度: 1.37 Å

PDB-5q2s:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 20)
手法: X-RAY DIFFRACTION / 解像度: 1.52 Å

PDB-5q2t:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 21)
手法: X-RAY DIFFRACTION / 解像度: 1.52 Å

PDB-5q2u:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 22)
手法: X-RAY DIFFRACTION / 解像度: 1.37 Å

PDB-5q2v:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 23)
手法: X-RAY DIFFRACTION / 解像度: 1.58 Å

PDB-5q2w:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 24)
手法: X-RAY DIFFRACTION / 解像度: 1.53 Å

PDB-5q2x:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 25)
手法: X-RAY DIFFRACTION / 解像度: 1.5 Å

PDB-5q2y:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 26)
手法: X-RAY DIFFRACTION / 解像度: 1.61 Å

PDB-5q2z:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 27)
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5q30:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 28)
手法: X-RAY DIFFRACTION / 解像度: 1.8 Å

PDB-5q31:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 29)
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5q32:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 30)
手法: X-RAY DIFFRACTION / 解像度: 1.87 Å

PDB-5q33:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 31)
手法: X-RAY DIFFRACTION / 解像度: 1.37 Å

PDB-5q34:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 32)
手法: X-RAY DIFFRACTION / 解像度: 1.49 Å

PDB-5q35:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 33)
手法: X-RAY DIFFRACTION / 解像度: 1.47 Å

PDB-5q36:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 34)
手法: X-RAY DIFFRACTION / 解像度: 1.39 Å

PDB-5q37:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 35)
手法: X-RAY DIFFRACTION / 解像度: 1.5 Å

PDB-5q38:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 36)
手法: X-RAY DIFFRACTION / 解像度: 1.39 Å

PDB-5q39:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 37)
手法: X-RAY DIFFRACTION / 解像度: 1.7 Å

PDB-5q3a:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 38)
手法: X-RAY DIFFRACTION / 解像度: 1.48 Å

PDB-5q3b:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 39)
手法: X-RAY DIFFRACTION / 解像度: 2.52 Å

PDB-5q3c:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 40)
手法: X-RAY DIFFRACTION / 解像度: 1.41 Å

PDB-5q3d:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 41)
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5q3e:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 42)
手法: X-RAY DIFFRACTION / 解像度: 1.49 Å

PDB-5q3f:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 43)
手法: X-RAY DIFFRACTION / 解像度: 1.39 Å

PDB-5q3g:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 44)
手法: X-RAY DIFFRACTION / 解像度: 1.29 Å

PDB-5q3h:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 45)
手法: X-RAY DIFFRACTION / 解像度: 1.56 Å

PDB-5q3i:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 46)
手法: X-RAY DIFFRACTION / 解像度: 1.53 Å

PDB-5q3j:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 47)
手法: X-RAY DIFFRACTION / 解像度: 1.44 Å

PDB-5q3k:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 48)
手法: X-RAY DIFFRACTION / 解像度: 1.39 Å

PDB-5q3l:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 49)
手法: X-RAY DIFFRACTION / 解像度: 1.61 Å

PDB-5q3m:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 50)
手法: X-RAY DIFFRACTION / 解像度: 1.34 Å

PDB-5q3n:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 51)
手法: X-RAY DIFFRACTION / 解像度: 1.62 Å

PDB-5q3o:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 52)
手法: X-RAY DIFFRACTION / 解像度: 1.6 Å

PDB-5q3p:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 53)
手法: X-RAY DIFFRACTION / 解像度: 1.44 Å

PDB-5q3q:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 54)
手法: X-RAY DIFFRACTION / 解像度: 1.39 Å

PDB-5q3r:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 55)
手法: X-RAY DIFFRACTION / 解像度: 1.5 Å

PDB-5q3s:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 56)
手法: X-RAY DIFFRACTION / 解像度: 1.72 Å

PDB-5q3t:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 57)
手法: X-RAY DIFFRACTION / 解像度: 1.52 Å

PDB-5q3u:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 58)
手法: X-RAY DIFFRACTION / 解像度: 1.49 Å

PDB-5q3v:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 59)
手法: X-RAY DIFFRACTION / 解像度: 1.52 Å

PDB-5q3w:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 60)
手法: X-RAY DIFFRACTION / 解像度: 1.5 Å

PDB-5q3x:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 61)
手法: X-RAY DIFFRACTION / 解像度: 1.38 Å

PDB-5q3y:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 62)
手法: X-RAY DIFFRACTION / 解像度: 1.45 Å

PDB-5q3z:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 63)
手法: X-RAY DIFFRACTION / 解像度: 1.84 Å

PDB-5q40:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 64)
手法: X-RAY DIFFRACTION / 解像度: 2.04 Å

PDB-5q41:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 65)
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5q42:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 66)
手法: X-RAY DIFFRACTION / 解像度: 1.68 Å

PDB-5q43:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 67)
手法: X-RAY DIFFRACTION / 解像度: 1.47 Å

PDB-5q44:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 69)
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5q45:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 70)
手法: X-RAY DIFFRACTION / 解像度: 1.64 Å

PDB-5q46:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 71)
手法: X-RAY DIFFRACTION / 解像度: 2.01 Å

PDB-5q47:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 72)
手法: X-RAY DIFFRACTION / 解像度: 1.38 Å

PDB-5q48:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 73)
手法: X-RAY DIFFRACTION / 解像度: 1.44 Å

PDB-5q49:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 74)
手法: X-RAY DIFFRACTION / 解像度: 1.38 Å

PDB-5q4a:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 75)
手法: X-RAY DIFFRACTION / 解像度: 1.83 Å

PDB-5q4b:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 76)
手法: X-RAY DIFFRACTION / 解像度: 1.6 Å

PDB-5q4c:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 77)
手法: X-RAY DIFFRACTION / 解像度: 2.73 Å

PDB-5q4d:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 78)
手法: X-RAY DIFFRACTION / 解像度: 1.8 Å

PDB-5q4e:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 79)
手法: X-RAY DIFFRACTION / 解像度: 1.39 Å

PDB-5q4f:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 80)
手法: X-RAY DIFFRACTION / 解像度: 1.97 Å

PDB-5q4g:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 81)
手法: X-RAY DIFFRACTION / 解像度: 1.75 Å

PDB-5q4h:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 82)
手法: X-RAY DIFFRACTION / 解像度: 1.53 Å

PDB-5q4i:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 83)
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5q4j:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 84)
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5q4k:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 85)
手法: X-RAY DIFFRACTION / 解像度: 1.47 Å

PDB-5q4l:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 86)
手法: X-RAY DIFFRACTION / 解像度: 1.6 Å

PDB-5q4m:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 87)
手法: X-RAY DIFFRACTION / 解像度: 1.6 Å

PDB-5q4n:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 88)
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5q4o:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 89)
手法: X-RAY DIFFRACTION / 解像度: 1.83 Å

PDB-5q4p:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 90)
手法: X-RAY DIFFRACTION / 解像度: 1.4 Å

PDB-5q4q:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 91)
手法: X-RAY DIFFRACTION / 解像度: 1.42 Å

PDB-5q4r:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 92)
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5q4s:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 93)
手法: X-RAY DIFFRACTION / 解像度: 1.72 Å

PDB-5q4t:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 94)
手法: X-RAY DIFFRACTION / 解像度: 1.77 Å

PDB-5q4u:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 95)
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5q4v:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 96)
手法: X-RAY DIFFRACTION / 解像度: 1.59 Å

PDB-5q4w:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 97)
手法: X-RAY DIFFRACTION / 解像度: 1.8 Å

PDB-5q4x:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 98)
手法: X-RAY DIFFRACTION / 解像度: 1.66 Å

PDB-5q4y:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 99)
手法: X-RAY DIFFRACTION / 解像度: 1.69 Å

PDB-5q4z:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 100)
手法: X-RAY DIFFRACTION / 解像度: 1.6 Å

PDB-5q50:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 101)
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5q51:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 102)
手法: X-RAY DIFFRACTION / 解像度: 1.34 Å

PDB-5q52:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 103)
手法: X-RAY DIFFRACTION / 解像度: 1.7 Å

PDB-5q53:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 104)
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5q54:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 105)
手法: X-RAY DIFFRACTION / 解像度: 1.3 Å

PDB-5q55:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 106)
手法: X-RAY DIFFRACTION / 解像度: 1.39 Å

PDB-5q56:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 107)
手法: X-RAY DIFFRACTION / 解像度: 1.87 Å

PDB-5q57:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 108)
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5q58:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 109)
手法: X-RAY DIFFRACTION / 解像度: 1.75 Å

PDB-5q59:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 110)
手法: X-RAY DIFFRACTION / 解像度: 1.86 Å

PDB-5q5a:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 111)
手法: X-RAY DIFFRACTION / 解像度: 2.26 Å

PDB-5q5b:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 112)
手法: X-RAY DIFFRACTION / 解像度: 1.58 Å

PDB-5q5c:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 113)
手法: X-RAY DIFFRACTION / 解像度: 1.38 Å

PDB-5q5d:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 114)
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5q5e:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 115)
手法: X-RAY DIFFRACTION / 解像度: 1.49 Å

PDB-5q5f:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 116)
手法: X-RAY DIFFRACTION / 解像度: 1.47 Å

PDB-5q5g:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 117)
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5q5h:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 118)
手法: X-RAY DIFFRACTION / 解像度: 1.36 Å

PDB-5q5i:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 119)
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5q5j:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 120)
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5q5k:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 121)
手法: X-RAY DIFFRACTION / 解像度: 2.81 Å

PDB-5q5l:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 122)
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5q5m:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 123)
手法: X-RAY DIFFRACTION / 解像度: 1.57 Å

PDB-5q5n:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 124)
手法: X-RAY DIFFRACTION / 解像度: 2.42 Å

PDB-5q5o:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 125)
手法: X-RAY DIFFRACTION / 解像度: 2.07 Å

PDB-5q5p:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 126)
手法: X-RAY DIFFRACTION / 解像度: 1.58 Å

PDB-5q5q:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 127)
手法: X-RAY DIFFRACTION / 解像度: 1.45 Å

PDB-5q5r:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 128)
手法: X-RAY DIFFRACTION / 解像度: 1.39 Å

PDB-5q5s:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 129)
手法: X-RAY DIFFRACTION / 解像度: 1.7 Å

PDB-5q5t:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 130)
手法: X-RAY DIFFRACTION / 解像度: 1.8 Å

PDB-5q5u:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 131)
手法: X-RAY DIFFRACTION / 解像度: 1.88 Å

PDB-5q5v:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 132)
手法: X-RAY DIFFRACTION / 解像度: 1.86 Å

PDB-5q5w:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 133)
手法: X-RAY DIFFRACTION / 解像度: 1.42 Å

PDB-5q5x:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 134)
手法: X-RAY DIFFRACTION / 解像度: 1.5 Å

PDB-5q5y:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 135)
手法: X-RAY DIFFRACTION / 解像度: 1.82 Å

PDB-5q5z:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 136)
手法: X-RAY DIFFRACTION / 解像度: 1.48 Å

PDB-5q60:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 137)
手法: X-RAY DIFFRACTION / 解像度: 1.4 Å

PDB-5q61:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 138)
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5q62:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 139)
手法: X-RAY DIFFRACTION / 解像度: 1.52 Å

PDB-5q63:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 140)
手法: X-RAY DIFFRACTION / 解像度: 1.82 Å

PDB-5q64:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 141)
手法: X-RAY DIFFRACTION / 解像度: 1.42 Å

PDB-5q65:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 142)
手法: X-RAY DIFFRACTION / 解像度: 1.78 Å

PDB-5q66:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 143)
手法: X-RAY DIFFRACTION / 解像度: 1.51 Å

PDB-5q67:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 144)
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5q68:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 145)
手法: X-RAY DIFFRACTION / 解像度: 1.86 Å

PDB-5q69:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 146)
手法: X-RAY DIFFRACTION / 解像度: 1.84 Å

PDB-5q6a:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 147)
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5q6b:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 148)
手法: X-RAY DIFFRACTION / 解像度: 2.62 Å

PDB-5q6c:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 149)
手法: X-RAY DIFFRACTION / 解像度: 1.53 Å

PDB-5q6d:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 150)
手法: X-RAY DIFFRACTION / 解像度: 1.48 Å

PDB-5q6e:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 151)
手法: X-RAY DIFFRACTION / 解像度: 1.47 Å

PDB-5q6f:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 152)
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5q6g:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 153)
手法: X-RAY DIFFRACTION / 解像度: 1.48 Å

PDB-5q6h:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 154)
手法: X-RAY DIFFRACTION / 解像度: 1.42 Å

PDB-5q6i:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 155)
手法: X-RAY DIFFRACTION / 解像度: 1.68 Å

PDB-5q6j:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 156)
手法: X-RAY DIFFRACTION / 解像度: 1.7 Å

PDB-5q6k:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 157)
手法: X-RAY DIFFRACTION / 解像度: 1.67 Å

PDB-5q6l:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 158)
手法: X-RAY DIFFRACTION / 解像度: 1.82 Å

PDB-5q6m:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 159)
手法: X-RAY DIFFRACTION / 解像度: 1.47 Å

PDB-5q6n:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 160)
手法: X-RAY DIFFRACTION / 解像度: 1.52 Å

PDB-5q6o:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 161)
手法: X-RAY DIFFRACTION / 解像度: 1.4 Å

PDB-5q6p:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 162)
手法: X-RAY DIFFRACTION / 解像度: 1.54 Å

PDB-5q6q:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 163)
手法: X-RAY DIFFRACTION / 解像度: 1.36 Å

PDB-5q6r:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 164)
手法: X-RAY DIFFRACTION / 解像度: 1.42 Å

PDB-5q6s:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 165)
手法: X-RAY DIFFRACTION / 解像度: 1.56 Å

PDB-5q6t:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 166)
手法: X-RAY DIFFRACTION / 解像度: 1.59 Å

PDB-5q6u:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 167)
手法: X-RAY DIFFRACTION / 解像度: 1.33 Å

PDB-5q6v:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 168)
手法: X-RAY DIFFRACTION / 解像度: 1.29 Å

PDB-5q6w:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 169)
手法: X-RAY DIFFRACTION / 解像度: 1.5 Å

PDB-5q6x:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 170)
手法: X-RAY DIFFRACTION / 解像度: 1.43 Å

PDB-5q6y:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 171)
手法: X-RAY DIFFRACTION / 解像度: 1.67 Å

PDB-5q6z:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 172)
手法: X-RAY DIFFRACTION / 解像度: 1.62 Å

PDB-5q70:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 173)
手法: X-RAY DIFFRACTION / 解像度: 1.31 Å

PDB-5q71:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 174)
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5q72:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 175)
手法: X-RAY DIFFRACTION / 解像度: 1.31 Å

PDB-5q73:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 176)
手法: X-RAY DIFFRACTION / 解像度: 1.36 Å

PDB-5q74:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 177)
手法: X-RAY DIFFRACTION / 解像度: 1.21 Å

PDB-5q75:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 178)
手法: X-RAY DIFFRACTION / 解像度: 1.36 Å

PDB-5q76:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 179)
手法: X-RAY DIFFRACTION / 解像度: 1.28 Å

PDB-5q77:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 180)
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5q78:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 181)
手法: X-RAY DIFFRACTION / 解像度: 1.25 Å

PDB-5q79:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 182)
手法: X-RAY DIFFRACTION / 解像度: 1.83 Å

PDB-5q7a:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 183)
手法: X-RAY DIFFRACTION / 解像度: 1.39 Å

PDB-5q7b:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 184)
手法: X-RAY DIFFRACTION / 解像度: 1.25 Å

PDB-5q7c:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 185)
手法: X-RAY DIFFRACTION / 解像度: 1.2 Å

PDB-5q7d:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 186)
手法: X-RAY DIFFRACTION / 解像度: 1.32 Å

PDB-5q7e:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 187)
手法: X-RAY DIFFRACTION / 解像度: 1.5 Å

PDB-5q7f:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 188)
手法: X-RAY DIFFRACTION / 解像度: 1.64 Å

PDB-5q7g:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 189)
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5q7h:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 190)
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5q7i:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 191)
手法: X-RAY DIFFRACTION / 解像度: 1.26 Å

PDB-5q7j:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 192)
手法: X-RAY DIFFRACTION / 解像度: 1.54 Å

PDB-5q7k:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 193)
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5q7l:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 194)
手法: X-RAY DIFFRACTION / 解像度: 1.61 Å

PDB-5q7m:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 195)
手法: X-RAY DIFFRACTION / 解像度: 1.26 Å

PDB-5q7n:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 196)
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5q7o:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 197)
手法: X-RAY DIFFRACTION / 解像度: 1.32 Å

PDB-5q7p:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 198)
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5q7q:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 199)
手法: X-RAY DIFFRACTION / 解像度: 1.76 Å

PDB-5q7r:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 200)
手法: X-RAY DIFFRACTION / 解像度: 1.62 Å

PDB-5q7s:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 201)
手法: X-RAY DIFFRACTION / 解像度: 1.31 Å

PDB-5q7t:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 202)
手法: X-RAY DIFFRACTION / 解像度: 1.67 Å

PDB-5q7u:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 203)
手法: X-RAY DIFFRACTION / 解像度: 2.11 Å

PDB-5q7v:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 204)
手法: X-RAY DIFFRACTION / 解像度: 1.62 Å

PDB-5q7w:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 205)
手法: X-RAY DIFFRACTION / 解像度: 1.27 Å

PDB-5q7x:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 206)
手法: X-RAY DIFFRACTION / 解像度: 1.69 Å

PDB-5q7y:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 207)
手法: X-RAY DIFFRACTION / 解像度: 1.39 Å

PDB-5q7z:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 208)
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5q80:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 209)
手法: X-RAY DIFFRACTION / 解像度: 1.43 Å

PDB-5q81:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 210)
手法: X-RAY DIFFRACTION / 解像度: 1.51 Å

PDB-5q82:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 211)
手法: X-RAY DIFFRACTION / 解像度: 1.2 Å

PDB-5q83:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 212)
手法: X-RAY DIFFRACTION / 解像度: 1.28 Å

PDB-5q84:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 213)
手法: X-RAY DIFFRACTION / 解像度: 1.88 Å

PDB-5q85:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 214)
手法: X-RAY DIFFRACTION / 解像度: 1.8 Å

PDB-5q86:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 215)
手法: X-RAY DIFFRACTION / 解像度: 1.31 Å

PDB-5q87:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 216)
手法: X-RAY DIFFRACTION / 解像度: 1.34 Å

PDB-5q88:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 217)
手法: X-RAY DIFFRACTION / 解像度: 1.78 Å

PDB-5q89:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 218)
手法: X-RAY DIFFRACTION / 解像度: 1.91 Å

PDB-5q8a:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 219)
手法: X-RAY DIFFRACTION / 解像度: 1.43 Å

PDB-5q8b:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 220)
手法: X-RAY DIFFRACTION / 解像度: 1.63 Å

PDB-5q8c:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 221)
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5q8d:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 222)
手法: X-RAY DIFFRACTION / 解像度: 1.23 Å

PDB-5q8e:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 223)
手法: X-RAY DIFFRACTION / 解像度: 1.63 Å

PDB-5q8f:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 224)
手法: X-RAY DIFFRACTION / 解像度: 1.36 Å

PDB-5q8g:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 225)
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5q8h:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 227)
手法: X-RAY DIFFRACTION / 解像度: 1.9 Å

PDB-5q8i:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 228)
手法: X-RAY DIFFRACTION / 解像度: 1.35 Å

PDB-5q8j:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 229)
手法: X-RAY DIFFRACTION / 解像度: 1.79 Å

PDB-5q8k:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 230)
手法: X-RAY DIFFRACTION / 解像度: 1.79 Å

PDB-5q8l:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 231)
手法: X-RAY DIFFRACTION / 解像度: 1.42 Å

PDB-5q8m:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 232)
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5q8n:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 233)
手法: X-RAY DIFFRACTION / 解像度: 1.41 Å

PDB-5q8o:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 234)
手法: X-RAY DIFFRACTION / 解像度: 1.67 Å

PDB-5q8p:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 235)
手法: X-RAY DIFFRACTION / 解像度: 1.45 Å

PDB-5q8q:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 236)
手法: X-RAY DIFFRACTION / 解像度: 1.89 Å

PDB-5q8r:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 237)
手法: X-RAY DIFFRACTION / 解像度: 1.9 Å

PDB-5q8s:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 238)
手法: X-RAY DIFFRACTION / 解像度: 1.61 Å

PDB-5q8t:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 239)
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5q8u:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 240)
手法: X-RAY DIFFRACTION / 解像度: 1.54 Å

PDB-5q8v:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 241)
手法: X-RAY DIFFRACTION / 解像度: 1.32 Å

PDB-5q8w:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 242)
手法: X-RAY DIFFRACTION / 解像度: 1.57 Å

PDB-5q8x:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 243)
手法: X-RAY DIFFRACTION / 解像度: 1.23 Å

PDB-5q8y:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 244)
手法: X-RAY DIFFRACTION / 解像度: 1.51 Å

PDB-5q8z:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 245)
手法: X-RAY DIFFRACTION / 解像度: 1.47 Å

PDB-5q90:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 246)
手法: X-RAY DIFFRACTION / 解像度: 1.49 Å

PDB-5q91:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 247)
手法: X-RAY DIFFRACTION / 解像度: 1.46 Å

PDB-5q92:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 248)
手法: X-RAY DIFFRACTION / 解像度: 2.11 Å

PDB-5q93:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 249)
手法: X-RAY DIFFRACTION / 解像度: 1.68 Å

PDB-5q94:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 250)
手法: X-RAY DIFFRACTION / 解像度: 1.9 Å

PDB-5q95:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 251)
手法: X-RAY DIFFRACTION / 解像度: 1.47 Å

PDB-5q96:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 252)
手法: X-RAY DIFFRACTION / 解像度: 1.83 Å

PDB-5q97:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 253)
手法: X-RAY DIFFRACTION / 解像度: 1.97 Å

PDB-5q98:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 254)
手法: X-RAY DIFFRACTION / 解像度: 1.76 Å

PDB-5q99:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 255)
手法: X-RAY DIFFRACTION / 解像度: 1.31 Å

PDB-5q9a:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 256)
手法: X-RAY DIFFRACTION / 解像度: 1.67 Å

PDB-5q9b:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 257)
手法: X-RAY DIFFRACTION / 解像度: 1.45 Å

PDB-5q9c:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 258)
手法: X-RAY DIFFRACTION / 解像度: 1.46 Å

PDB-5q9d:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 259)
手法: X-RAY DIFFRACTION / 解像度: 1.69 Å

PDB-5q9e:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 260)
手法: X-RAY DIFFRACTION / 解像度: 1.45 Å

PDB-5q9f:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 261)
手法: X-RAY DIFFRACTION / 解像度: 1.28 Å

PDB-5q9g:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 262)
手法: X-RAY DIFFRACTION / 解像度: 1.6 Å

PDB-5q9h:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 263)
手法: X-RAY DIFFRACTION / 解像度: 1.81 Å

PDB-5q9i:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 264)
手法: X-RAY DIFFRACTION / 解像度: 1.46 Å

PDB-5q9j:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 265)
手法: X-RAY DIFFRACTION / 解像度: 1.76 Å

PDB-5q9k:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 266)
手法: X-RAY DIFFRACTION / 解像度: 1.78 Å

PDB-5q9l:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 267)
手法: X-RAY DIFFRACTION / 解像度: 1.59 Å

PDB-5q9m:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 268)
手法: X-RAY DIFFRACTION / 解像度: 1.3 Å

PDB-5q9n:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 269)
手法: X-RAY DIFFRACTION / 解像度: 1.47 Å

PDB-5q9o:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 270)
手法: X-RAY DIFFRACTION / 解像度: 1.37 Å

PDB-5q9p:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 271)
手法: X-RAY DIFFRACTION / 解像度: 1.48 Å

PDB-5q9q:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 272)
手法: X-RAY DIFFRACTION / 解像度: 1.5 Å

PDB-5q9r:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 273)
手法: X-RAY DIFFRACTION / 解像度: 1.72 Å

PDB-5q9s:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 274)
手法: X-RAY DIFFRACTION / 解像度: 1.43 Å

PDB-5q9t:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 275)
手法: X-RAY DIFFRACTION / 解像度: 1.37 Å

PDB-5q9u:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 276)
手法: X-RAY DIFFRACTION / 解像度: 1.49 Å

PDB-5q9v:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 277)
手法: X-RAY DIFFRACTION / 解像度: 1.43 Å

PDB-5q9w:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 278)
手法: X-RAY DIFFRACTION / 解像度: 1.53 Å

PDB-5q9x:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 279)
手法: X-RAY DIFFRACTION / 解像度: 1.67 Å

PDB-5q9y:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 280)
手法: X-RAY DIFFRACTION / 解像度: 1.64 Å

PDB-5q9z:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 281)
手法: X-RAY DIFFRACTION / 解像度: 1.77 Å

PDB-5qa0:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 282)
手法: X-RAY DIFFRACTION / 解像度: 1.47 Å

PDB-5qa1:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 283)
手法: X-RAY DIFFRACTION / 解像度: 1.46 Å

PDB-5qa2:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 284)
手法: X-RAY DIFFRACTION / 解像度: 1.56 Å

PDB-5qha:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with PCM-0102951
手法: X-RAY DIFFRACTION / 解像度: 1.57 Å

PDB-5qht:
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000065a
手法: X-RAY DIFFRACTION / 解像度: 1.05 Å

PDB-5qhv:
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000299a
手法: X-RAY DIFFRACTION / 解像度: 1.05 Å

PDB-5qi4:
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000466a
手法: X-RAY DIFFRACTION / 解像度: 1.2 Å

PDB-5qi6:
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000597a
手法: X-RAY DIFFRACTION / 解像度: 1.1 Å

PDB-5qi8:
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000605a
手法: X-RAY DIFFRACTION / 解像度: 1.09 Å

PDB-5qi9:
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000711a
手法: X-RAY DIFFRACTION / 解像度: 1.05 Å

PDB-5qj5:
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with Z44592329
手法: X-RAY DIFFRACTION / 解像度: 1.72 Å

PDB-5qoh:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with XST00000847b
手法: X-RAY DIFFRACTION / 解像度: 1.93 Å

PDB-5qoi:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000213a
手法: X-RAY DIFFRACTION / 解像度: 1.99 Å

PDB-5qoj:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOCR000171b
手法: X-RAY DIFFRACTION / 解像度: 2.05 Å

PDB-5qok:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000294a
手法: X-RAY DIFFRACTION / 解像度: 2.28 Å

PDB-5qol:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000435a
手法: X-RAY DIFFRACTION / 解像度: 1.85 Å

PDB-5qom:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000576a
手法: X-RAY DIFFRACTION / 解像度: 1.87 Å

PDB-5qon:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000446a
手法: X-RAY DIFFRACTION / 解像度: 1.8 Å

PDB-5qoo:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000144a
手法: X-RAY DIFFRACTION / 解像度: 1.56 Å

PDB-5qop:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with NUOOA000023a
手法: X-RAY DIFFRACTION / 解像度: 1.86 Å

PDB-5qoq:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z2895259680
手法: X-RAY DIFFRACTION / 解像度: 1.49 Å

PDB-5qor:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1203490773
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5qos:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1187701032
手法: X-RAY DIFFRACTION / 解像度: 1.7 Å

PDB-5qot:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1592710382
手法: X-RAY DIFFRACTION / 解像度: 1.68 Å

PDB-5qou:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z296300542
手法: X-RAY DIFFRACTION / 解像度: 2.19 Å

PDB-5qov:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1699011516
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5qow:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z2895259675
手法: X-RAY DIFFRACTION / 解像度: 1.82 Å

PDB-5qox:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z2212124043
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5qoy:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with YW-FY-378
手法: X-RAY DIFFRACTION / 解像度: 1.69 Å

PDB-5qoz:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with PB1787571279
手法: X-RAY DIFFRACTION / 解像度: 1.7 Å

PDB-5qp0:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z454376544
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5qp1:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1190363272
手法: X-RAY DIFFRACTION / 解像度: 1.79 Å

PDB-5qp2:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1170065264
手法: X-RAY DIFFRACTION / 解像度: 1.83 Å

PDB-5qp3:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1494850193
手法: X-RAY DIFFRACTION / 解像度: 1.75 Å

PDB-5qp4:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z450133538
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5qp5:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z2895259681
手法: X-RAY DIFFRACTION / 解像度: 1.9 Å

PDB-5qp6:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1662802141
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5qp7:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with PB1230873739
手法: X-RAY DIFFRACTION / 解像度: 1.88 Å

PDB-5qp8:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with PB1787571279
手法: X-RAY DIFFRACTION / 解像度: 1.64 Å

PDB-5qp9:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z100435060
手法: X-RAY DIFFRACTION / 解像度: 1.72 Å

PDB-5qpa:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000449a
手法: X-RAY DIFFRACTION / 解像度: 1.61 Å

PDB-5qpb:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000701a
手法: X-RAY DIFFRACTION / 解像度: 1.68 Å

PDB-5qqd:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with Z56880342
手法: X-RAY DIFFRACTION / 解像度: 1.91 Å

PDB-5qqe:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-531-494
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5qqf:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-004-412-710
手法: X-RAY DIFFRACTION / 解像度: 2.26 Å

PDB-5qqg:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-541-216
手法: X-RAY DIFFRACTION / 解像度: 2.23 Å

PDB-5qqh:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-020-096-465
手法: X-RAY DIFFRACTION / 解像度: 2.09 Å

PDB-5qqi:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-178-994
手法: X-RAY DIFFRACTION / 解像度: 2.08 Å

PDB-5qqj:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-587-558
手法: X-RAY DIFFRACTION / 解像度: 1.9 Å

PDB-5qqk:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-359-835
手法: X-RAY DIFFRACTION / 解像度: 2.24 Å

PDB-5qql:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-565-301
手法: X-RAY DIFFRACTION / 解像度: 2.25 Å

PDB-5qqm:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-565-325
手法: X-RAY DIFFRACTION / 解像度: 2.02 Å

PDB-5qqn:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-010-382-606
手法: X-RAY DIFFRACTION / 解像度: 2.26 Å

PDB-5qqq:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434857
手法: X-RAY DIFFRACTION / 解像度: 1.93 Å

PDB-5qqr:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1171217421
手法: X-RAY DIFFRACTION / 解像度: 1.46 Å

PDB-5qqs:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z275151340
手法: X-RAY DIFFRACTION / 解像度: 1.85 Å

PDB-5qqt:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434834
手法: X-RAY DIFFRACTION / 解像度: 1.67 Å

PDB-5qqu:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1348371854
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5qqv:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1545312521
手法: X-RAY DIFFRACTION / 解像度: 1.52 Å

PDB-5qqw:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z136583524
手法: X-RAY DIFFRACTION / 解像度: 1.56 Å

PDB-5qqx:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z373768900
手法: X-RAY DIFFRACTION / 解像度: 1.5 Å

PDB-5qqy:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434899
手法: X-RAY DIFFRACTION / 解像度: 1.49 Å

PDB-5qqz:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1675346324
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5qr0:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z730649594
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5qr1:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z396380540
手法: X-RAY DIFFRACTION / 解像度: 1.44 Å

PDB-5qr2:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1348371854
手法: X-RAY DIFFRACTION / 解像度: 1.66 Å

PDB-5qr3:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z915492990
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5qr4:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434826
手法: X-RAY DIFFRACTION / 解像度: 1.57 Å

PDB-5qr5:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2241115980
手法: X-RAY DIFFRACTION / 解像度: 1.49 Å

PDB-5qr6:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z44567722
手法: X-RAY DIFFRACTION / 解像度: 1.52 Å

PDB-5qr7:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z57299529
手法: X-RAY DIFFRACTION / 解像度: 1.74 Å

PDB-5qr8:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z57258487
手法: X-RAY DIFFRACTION / 解像度: 1.85 Å

PDB-5qr9:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z31478129
手法: X-RAY DIFFRACTION / 解像度: 1.62 Å

PDB-5qra:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1101755952
手法: X-RAY DIFFRACTION / 解像度: 1.72 Å

PDB-5qrb:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434868
手法: X-RAY DIFFRACTION / 解像度: 1.72 Å

PDB-5qrc:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z31721798
手法: X-RAY DIFFRACTION / 解像度: 1.82 Å

PDB-5qrd:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1328968520
手法: X-RAY DIFFRACTION / 解像度: 1.76 Å

PDB-5qre:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z117233350
手法: X-RAY DIFFRACTION / 解像度: 1.67 Å

PDB-5qrf:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z373768900
手法: X-RAY DIFFRACTION / 解像度: 2.03 Å

PDB-5qrg:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z275151340
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5qrh:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z32327641
手法: X-RAY DIFFRACTION / 解像度: 1.81 Å

PDB-5qri:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z2856434826
手法: X-RAY DIFFRACTION / 解像度: 1.83 Å

PDB-5qrj:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z416341642
手法: X-RAY DIFFRACTION / 解像度: 1.81 Å

PDB-5qrk:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z275179758
手法: X-RAY DIFFRACTION / 解像度: 1.63 Å

PDB-5qrl:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z437516460
手法: X-RAY DIFFRACTION / 解像度: 1.76 Å

PDB-5qrm:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1899842917
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5qrn:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z54226006
手法: X-RAY DIFFRACTION / 解像度: 1.62 Å

PDB-5qro:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1506050651
手法: X-RAY DIFFRACTION / 解像度: 1.61 Å

PDB-5qrp:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z2442270563
手法: X-RAY DIFFRACTION / 解像度: 1.67 Å

PDB-5qrq:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z645232558
手法: X-RAY DIFFRACTION / 解像度: 2.1 Å

PDB-5qrr:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z31720228
手法: X-RAY DIFFRACTION / 解像度: 1.69 Å

PDB-5qrs:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1891773393
手法: X-RAY DIFFRACTION / 解像度: 2.06 Å

PDB-5qrt:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z31735562
手法: X-RAY DIFFRACTION / 解像度: 1.77 Å

PDB-5qru:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z235341991
手法: X-RAY DIFFRACTION / 解像度: 1.76 Å

PDB-5qrv:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z198194396
手法: X-RAY DIFFRACTION / 解像度: 1.67 Å

PDB-5qrw:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1509882419
手法: X-RAY DIFFRACTION / 解像度: 1.74 Å

PDB-5qrx:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z364328788
手法: X-RAY DIFFRACTION / 解像度: 1.87 Å

PDB-5qry:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z2856434890
手法: X-RAY DIFFRACTION / 解像度: 1.58 Å

PDB-5qrz:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1998104358
手法: X-RAY DIFFRACTION / 解像度: 1.96 Å

PDB-5qs0:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z274555794
手法: X-RAY DIFFRACTION / 解像度: 1.6 Å

PDB-5qs1:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1954800564
手法: X-RAY DIFFRACTION / 解像度: 1.66 Å

PDB-5qs2:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z291279160
手法: X-RAY DIFFRACTION / 解像度: 1.68 Å

PDB-5qs3:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z198195770
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5qs4:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z30820160
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5qs5:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z32400357
手法: X-RAY DIFFRACTION / 解像度: 1.81 Å

PDB-5qs6:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z44592329
手法: X-RAY DIFFRACTION / 解像度: 1.67 Å

PDB-5qs7:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z32327641
手法: X-RAY DIFFRACTION / 解像度: 1.66 Å

PDB-5qs8:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z1432018343
手法: X-RAY DIFFRACTION / 解像度: 1.47 Å

PDB-5qs9:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z48847594
手法: X-RAY DIFFRACTION / 解像度: 1.43 Å

PDB-5qsa:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434778
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5qsb:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434874
手法: X-RAY DIFFRACTION / 解像度: 1.82 Å

PDB-5qsc:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z300245038
手法: X-RAY DIFFRACTION / 解像度: 1.62 Å

PDB-5qsd:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z54571979
手法: X-RAY DIFFRACTION / 解像度: 1.87 Å

PDB-5qse:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2017168803
手法: X-RAY DIFFRACTION / 解像度: 2.01 Å

PDB-5qsf:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434814
手法: X-RAY DIFFRACTION / 解像度: 1.96 Å

PDB-5qsg:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434903
手法: X-RAY DIFFRACTION / 解像度: 1.87 Å

PDB-5qsh:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434868
手法: X-RAY DIFFRACTION / 解像度: 1.9 Å

PDB-5qsi:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z933326822
手法: X-RAY DIFFRACTION / 解像度: 1.64 Å

PDB-5qsj:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z198194394
手法: X-RAY DIFFRACTION / 解像度: 1.49 Å

PDB-5qsk:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434906
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5qsl:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1273312153
手法: X-RAY DIFFRACTION / 解像度: 2.2 Å

PDB-5qsm:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z57261895
手法: X-RAY DIFFRACTION / 解像度: 2.74 Å

PDB-5qsn:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z1272480091
手法: X-RAY DIFFRACTION / 解像度: 2.66 Å

PDB-5qso:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z466628048
手法: X-RAY DIFFRACTION / 解像度: 2.7 Å

PDB-5qsp:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434929
手法: X-RAY DIFFRACTION / 解像度: 2.89 Å

PDB-5qsq:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z396380540
手法: X-RAY DIFFRACTION / 解像度: 2.48 Å

PDB-5qsr:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z136583524
手法: X-RAY DIFFRACTION / 解像度: 3.28 Å

PDB-5qss:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z33452282
手法: X-RAY DIFFRACTION / 解像度: 3.08 Å

PDB-5qst:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2447286438
手法: X-RAY DIFFRACTION / 解像度: 2.58 Å

PDB-5qsu:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434926
手法: X-RAY DIFFRACTION / 解像度: 2.73 Å

PDB-5qsv:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434783
手法: X-RAY DIFFRACTION / 解像度: 2.76 Å

PDB-5qsw:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434884
手法: X-RAY DIFFRACTION / 解像度: 3.03 Å

PDB-5qsx:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434812
手法: X-RAY DIFFRACTION / 解像度: 2.34 Å

PDB-5qsy:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z755044716
手法: X-RAY DIFFRACTION / 解像度: 2.4 Å

PDB-5qsz:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z1267773786
手法: X-RAY DIFFRACTION / 解像度: 3.08 Å

PDB-5qt0:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z321318226
手法: X-RAY DIFFRACTION / 解像度: 2.1 Å

PDB-5qt1:
PanDDA analysis group deposition -- Partial occupancy interpretation of PanDDA event map: SETDB1 in complex with FMOMB000017a
手法: X-RAY DIFFRACTION / 解像度: 1.58 Å

PDB-5qt2:
PanDDA analysis group deposition -- Partial occupancy interpretation of PanDDA event map: SETDB1 in complex with FMOPL000074a
手法: X-RAY DIFFRACTION / 解像度: 1.59 Å

PDB-5qtl:
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with GB-0804
手法: X-RAY DIFFRACTION / 解像度: 1.73 Å

PDB-5qtm:
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with FS-2639
手法: X-RAY DIFFRACTION / 解像度: 1.79 Å

PDB-5qtn:
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with SS-4432
手法: X-RAY DIFFRACTION / 解像度: 1.83 Å

PDB-5qto:
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with 1R-0641
手法: X-RAY DIFFRACTION / 解像度: 1.67 Å

PDB-5qtp:
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with AE-0227
手法: X-RAY DIFFRACTION / 解像度: 1.73 Å

PDB-5qtq:
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with FS-1169
手法: X-RAY DIFFRACTION / 解像度: 1.82 Å

PDB-5qtr:
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with FS-3764
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5qts:
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with 8J-537S
手法: X-RAY DIFFRACTION / 解像度: 1.85 Å

PDB-5r4g:
PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000621a
手法: X-RAY DIFFRACTION / 解像度: 1.25 Å

PDB-5r4h:
PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000287a
手法: X-RAY DIFFRACTION / 解像度: 1.18 Å

PDB-5r4i:
PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000443a
手法: X-RAY DIFFRACTION / 解像度: 1.28 Å

PDB-5r4j:
PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000280a
手法: X-RAY DIFFRACTION / 解像度: 1.39 Å

PDB-5r4k:
PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000292a
手法: X-RAY DIFFRACTION / 解像度: 1.17 Å

PDB-5r4l:
PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000349a
手法: X-RAY DIFFRACTION / 解像度: 1.13 Å

PDB-5r4m:
PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000513a
手法: X-RAY DIFFRACTION / 解像度: 1.11 Å

PDB-5r4n:
PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000061a
手法: X-RAY DIFFRACTION / 解像度: 1.28 Å

PDB-5r4p:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with NM450-1
手法: X-RAY DIFFRACTION / 解像度: 1.78 Å

PDB-5r4q:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with NM466-1
手法: X-RAY DIFFRACTION / 解像度: 1.49 Å

PDB-5r4r:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with EN08775-42
手法: X-RAY DIFFRACTION / 解像度: 1.5 Å

PDB-5r4s:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with EN08775-45
手法: X-RAY DIFFRACTION / 解像度: 1.61 Å

PDB-5r4t:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with SK-430
手法: X-RAY DIFFRACTION / 解像度: 1.68 Å

PDB-5r4u:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with EN08775-43
手法: X-RAY DIFFRACTION / 解像度: 1.92 Å

PDB-5r50:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13371a
手法: X-RAY DIFFRACTION / 解像度: 1.87 Å

PDB-5r51:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14003a
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5r52:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14004a
手法: X-RAY DIFFRACTION / 解像度: 1.48 Å

PDB-5r53:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13854a
手法: X-RAY DIFFRACTION / 解像度: 1.4 Å

PDB-5r54:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13582a
手法: X-RAY DIFFRACTION / 解像度: 1.79 Å

PDB-5r55:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13369a
手法: X-RAY DIFFRACTION / 解像度: 1.48 Å

PDB-5r56:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13688a
手法: X-RAY DIFFRACTION / 解像度: 1.51 Å

PDB-5r57:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N08253b
手法: X-RAY DIFFRACTION / 解像度: 1.44 Å

PDB-5r58:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13542a
手法: X-RAY DIFFRACTION / 解像度: 1.98 Å

PDB-5r59:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13441a
手法: X-RAY DIFFRACTION / 解像度: 2.11 Å

PDB-5r5a:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13663a
手法: X-RAY DIFFRACTION / 解像度: 1.44 Å

PDB-5r5b:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13725a
手法: X-RAY DIFFRACTION / 解像度: 1.53 Å

PDB-5r5c:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13956a
手法: X-RAY DIFFRACTION / 解像度: 1.68 Å

PDB-5r5d:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13564a
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5r5e:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13848a
手法: X-RAY DIFFRACTION / 解像度: 1.58 Å

PDB-5r5f:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13793a
手法: X-RAY DIFFRACTION / 解像度: 1.63 Å

PDB-5r5g:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13707a
手法: X-RAY DIFFRACTION / 解像度: 1.77 Å

PDB-5r5h:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13706a
手法: X-RAY DIFFRACTION / 解像度: 1.79 Å

PDB-5r5i:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N06325b
手法: X-RAY DIFFRACTION / 解像度: 1.7 Å

PDB-5r5j:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13964a
手法: X-RAY DIFFRACTION / 解像度: 1.98 Å

PDB-5r5k:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13960a
手法: X-RAY DIFFRACTION / 解像度: 1.6 Å

PDB-5r5l:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13589a
手法: X-RAY DIFFRACTION / 解像度: 1.63 Å

PDB-5r5m:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14123a
手法: X-RAY DIFFRACTION / 解像度: 1.6 Å

PDB-5r5n:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13595a
手法: X-RAY DIFFRACTION / 解像度: 1.87 Å

PDB-5r5o:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14027a
手法: X-RAY DIFFRACTION / 解像度: 1.79 Å

PDB-5r5p:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13910a
手法: X-RAY DIFFRACTION / 解像度: 1.53 Å

PDB-5r5q:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13920a
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5r5r:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14078a
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5r5s:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13775a
手法: X-RAY DIFFRACTION / 解像度: 1.5 Å

PDB-5r5t:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1251207602
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5r5u:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1545312521
手法: X-RAY DIFFRACTION / 解像度: 1.52 Å

PDB-5r5v:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434824
手法: X-RAY DIFFRACTION / 解像度: 1.7 Å

PDB-5r5w:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434942
手法: X-RAY DIFFRACTION / 解像度: 1.6 Å

PDB-5r5x:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1259335913
手法: X-RAY DIFFRACTION / 解像度: 1.56 Å

PDB-5r5y:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z509756472
手法: X-RAY DIFFRACTION / 解像度: 1.57 Å

PDB-5r5z:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434821
手法: X-RAY DIFFRACTION / 解像度: 1.67 Å

PDB-5r60:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z19735067
手法: X-RAY DIFFRACTION / 解像度: 1.79 Å

PDB-5r61:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1578665941
手法: X-RAY DIFFRACTION / 解像度: 1.38 Å

PDB-5r62:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434840
手法: X-RAY DIFFRACTION / 解像度: 1.4 Å

PDB-5r63:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z319545618
手法: X-RAY DIFFRACTION / 解像度: 1.59 Å

PDB-5r64:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with FMOPL000464a
手法: X-RAY DIFFRACTION / 解像度: 1.84 Å

PDB-5r65:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with FMOPL000387a
手法: X-RAY DIFFRACTION / 解像度: 2.28 Å

PDB-5r66:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with FMOPL000198a
手法: X-RAY DIFFRACTION / 解像度: 2.02 Å

PDB-5r67:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with FMOPL000589a
手法: X-RAY DIFFRACTION / 解像度: 1.52 Å

PDB-5rhg:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z235341991
手法: X-RAY DIFFRACTION / 解像度: 1.41 Å

PDB-5rhh:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1515654336
手法: X-RAY DIFFRACTION / 解像度: 1.59 Å

PDB-5rhi:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z198194396
手法: X-RAY DIFFRACTION / 解像度: 1.45 Å

PDB-5rhj:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z126932614
手法: X-RAY DIFFRACTION / 解像度: 1.5 Å

PDB-5rhk:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z87615031
手法: X-RAY DIFFRACTION / 解像度: 1.52 Å

PDB-5rhl:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z425387594
手法: X-RAY DIFFRACTION / 解像度: 1.43 Å

PDB-5rhm:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1454310449
手法: X-RAY DIFFRACTION / 解像度: 1.68 Å

PDB-5rho:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1444783243
手法: X-RAY DIFFRACTION / 解像度: 1.49 Å

PDB-5rhp:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z2856434938
手法: X-RAY DIFFRACTION / 解像度: 1.61 Å

PDB-5rhq:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z235449082
手法: X-RAY DIFFRACTION / 解像度: 1.49 Å

PDB-5rhr:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1348559502
手法: X-RAY DIFFRACTION / 解像度: 1.46 Å

PDB-5rhs:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z274555794
手法: X-RAY DIFFRACTION / 解像度: 1.53 Å

PDB-5rht:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z291279160
手法: X-RAY DIFFRACTION / 解像度: 1.63 Å

PDB-5rhu:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1703168683
手法: X-RAY DIFFRACTION / 解像度: 1.61 Å

PDB-5rhv:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z62645406
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5rhw:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z31222641
手法: X-RAY DIFFRACTION / 解像度: 1.62 Å

PDB-5rhx:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1324080698
手法: X-RAY DIFFRACTION / 解像度: 1.73 Å

PDB-5rvw:
PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z1587220559
手法: X-RAY DIFFRACTION / 解像度: 1.614 Å

PDB-5rvx:
PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z804566442
手法: X-RAY DIFFRACTION / 解像度: 1.661 Å

PDB-5rvy:
PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z437516460
手法: X-RAY DIFFRACTION / 解像度: 1.609 Å

PDB-5rvz:
PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z1929757385
手法: X-RAY DIFFRACTION / 解像度: 1.98 Å

PDB-5rw0:
PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z2444997446
手法: X-RAY DIFFRACTION / 解像度: 1.673 Å

PDB-5sdc:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z2856434912
手法: X-RAY DIFFRACTION / 解像度: 1.928 Å

PDB-5sdd:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z2856434879
手法: X-RAY DIFFRACTION / 解像度: 1.839 Å

PDB-5sde:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z1619978933
手法: X-RAY DIFFRACTION / 解像度: 1.854 Å

PDB-5sdf:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z2856434834
手法: X-RAY DIFFRACTION / 解像度: 1.877 Å

PDB-5sdg:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z136583524
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5sdh:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z2856434854
手法: X-RAY DIFFRACTION / 解像度: 2.313 Å

PDB-5sdi:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z44592329
手法: X-RAY DIFFRACTION / 解像度: 1.898 Å

PDB-5sdj:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z32327641
手法: X-RAY DIFFRACTION / 解像度: 2.041 Å

PDB-5sdk:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z416341642
手法: X-RAY DIFFRACTION / 解像度: 1.977 Å

PDB-5sdl:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z321318226
手法: X-RAY DIFFRACTION / 解像度: 2.44 Å

PDB-5sdm:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z1328078283
手法: X-RAY DIFFRACTION / 解像度: 2.039 Å

PDB-5sdn:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z437584380
手法: X-RAY DIFFRACTION / 解像度: 2.023 Å

PDB-5sdo:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z19735067
手法: X-RAY DIFFRACTION / 解像度: 2.051 Å

PDB-5sdp:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z2277255954
手法: X-RAY DIFFRACTION / 解像度: 2.195 Å

PDB-5sdq:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z2856434887
手法: X-RAY DIFFRACTION / 解像度: 1.92 Å

PDB-5sdr:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z1273312153
手法: X-RAY DIFFRACTION / 解像度: 2.077 Å

PDB-5skw:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1272494722
手法: X-RAY DIFFRACTION / 解像度: 2.093 Å

PDB-5skx:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z126932614
手法: X-RAY DIFFRACTION / 解像度: 2.342 Å

PDB-5sky:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z466628048
手法: X-RAY DIFFRACTION / 解像度: 2.25 Å

PDB-5skz:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z57258487
手法: X-RAY DIFFRACTION / 解像度: 1.96 Å

PDB-5sl0:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z57260516
手法: X-RAY DIFFRACTION / 解像度: 2.001 Å

PDB-5sl1:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1273312153
手法: X-RAY DIFFRACTION / 解像度: 2.383 Å

PDB-5sl2:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z100643660
手法: X-RAY DIFFRACTION / 解像度: 1.739 Å

PDB-5sl3:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z223688272
手法: X-RAY DIFFRACTION / 解像度: 1.99 Å

PDB-5sl4:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z383202616
手法: X-RAY DIFFRACTION / 解像度: 1.936 Å

PDB-5sl5:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z32014663
手法: X-RAY DIFFRACTION / 解像度: 2.36 Å

PDB-5sl6:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z256709556
手法: X-RAY DIFFRACTION / 解像度: 2.289 Å

PDB-5sl7:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1186029914
手法: X-RAY DIFFRACTION / 解像度: 1.841 Å

PDB-5sl8:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434762
手法: X-RAY DIFFRACTION / 解像度: 2.07 Å

PDB-5sl9:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z54571979
手法: X-RAY DIFFRACTION / 解像度: 1.749 Å

PDB-5sla:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1003207278
手法: X-RAY DIFFRACTION / 解像度: 1.7 Å

PDB-5slb:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z744930860
手法: X-RAY DIFFRACTION / 解像度: 1.8 Å

PDB-5slc:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1849009686
手法: X-RAY DIFFRACTION / 解像度: 1.668 Å

PDB-5sld:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1246465616
手法: X-RAY DIFFRACTION / 解像度: 1.581 Å

PDB-5sle:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z56880342
手法: X-RAY DIFFRACTION / 解像度: 2.009 Å

PDB-5slf:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z198195770
手法: X-RAY DIFFRACTION / 解像度: 2.01 Å

PDB-5slg:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z32400357
手法: X-RAY DIFFRACTION / 解像度: 1.97 Å

PDB-5slh:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z65532537
手法: X-RAY DIFFRACTION / 解像度: 1.819 Å

PDB-5sli:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1003146540
手法: X-RAY DIFFRACTION / 解像度: 2.3 Å

PDB-5slj:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1430613393
手法: X-RAY DIFFRACTION / 解像度: 2.31 Å

PDB-5slk:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1354370680
手法: X-RAY DIFFRACTION / 解像度: 2.21 Å

PDB-5sll:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z54615640
手法: X-RAY DIFFRACTION / 解像度: 1.807 Å

PDB-5slm:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z28290384
手法: X-RAY DIFFRACTION / 解像度: 2.05 Å

PDB-5sln:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z57299529
手法: X-RAY DIFFRACTION / 解像度: 2.208 Å

PDB-5slo:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z56983806
手法: X-RAY DIFFRACTION / 解像度: 1.829 Å

PDB-5slp:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z373768898
手法: X-RAY DIFFRACTION / 解像度: 1.819 Å

PDB-5slq:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434829
手法: X-RAY DIFFRACTION / 解像度: 2.112 Å

PDB-5slr:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2073741691
手法: X-RAY DIFFRACTION / 解像度: 1.86 Å

PDB-5sls:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1373445602
手法: X-RAY DIFFRACTION / 解像度: 2.29 Å

PDB-5slt:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1816233707
手法: X-RAY DIFFRACTION / 解像度: 1.901 Å

PDB-5slu:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1796014543
手法: X-RAY DIFFRACTION / 解像度: 2.09 Å

PDB-5slv:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434942
手法: X-RAY DIFFRACTION / 解像度: 2.049 Å

PDB-5slw:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1310876699
手法: X-RAY DIFFRACTION / 解像度: 2.05 Å

PDB-5slx:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z752989138
手法: X-RAY DIFFRACTION / 解像度: 1.76 Å

PDB-5sly:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1526504764
手法: X-RAY DIFFRACTION / 解像度: 2.018 Å

PDB-5slz:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2072621991
手法: X-RAY DIFFRACTION / 解像度: 2.54 Å

PDB-5sm0:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z32665176
手法: X-RAY DIFFRACTION / 解像度: 2.086 Å

PDB-5sm1:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z68277692
手法: X-RAY DIFFRACTION / 解像度: 1.941 Å

PDB-5sm2:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z3006151474
手法: X-RAY DIFFRACTION / 解像度: 1.781 Å

PDB-5sm3:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z943693514
手法: X-RAY DIFFRACTION / 解像度: 2.198 Å

PDB-5sm4:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434944
手法: X-RAY DIFFRACTION / 解像度: 2.16 Å

PDB-5sm5:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434807
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5sm6:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1899842917
手法: X-RAY DIFFRACTION / 解像度: 2.29 Å

PDB-5sm7:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1247413608
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5sm8:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2027158783
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5sm9:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2234920345
手法: X-RAY DIFFRACTION / 解像度: 2.01 Å

PDB-5sma:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434890
手法: X-RAY DIFFRACTION / 解像度: 2.011 Å

PDB-5smb:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z419995480
手法: X-RAY DIFFRACTION / 解像度: 2.181 Å

PDB-5smc:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2033637875
手法: X-RAY DIFFRACTION / 解像度: 2.19 Å

PDB-5smd:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z274575916
手法: X-RAY DIFFRACTION / 解像度: 1.826 Å

PDB-5sme:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z437584380
手法: X-RAY DIFFRACTION / 解像度: 1.91 Å

PDB-5smf:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z56791867
手法: X-RAY DIFFRACTION / 解像度: 2.011 Å

PDB-5smg:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2092370954
手法: X-RAY DIFFRACTION / 解像度: 1.87 Å

PDB-5smh:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434938
手法: X-RAY DIFFRACTION / 解像度: 2.64 Å

PDB-5smi:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z71580604
手法: X-RAY DIFFRACTION / 解像度: 2.08 Å

PDB-7fus:
PanDDA analysis group deposition -- PHIP in complex with Z44602363
手法: X-RAY DIFFRACTION / 解像度: 1.15 Å

PDB-7fut:
PanDDA analysis group deposition -- PHIP in complex with Z44602357
手法: X-RAY DIFFRACTION / 解像度: 1.18 Å

PDB-7fuu:
PanDDA analysis group deposition -- PHIP in complex with Z445977856
手法: X-RAY DIFFRACTION / 解像度: 1.16 Å

PDB-7fuv:
PanDDA analysis group deposition -- PHIP in complex with Z183376720
手法: X-RAY DIFFRACTION / 解像度: 1.19 Å

PDB-7fuw:
PanDDA analysis group deposition -- PHIP in complex with Z961579360
手法: X-RAY DIFFRACTION / 解像度: 1.19 Å

PDB-7fux:
PanDDA analysis group deposition -- PHIP in complex with Z183480798
手法: X-RAY DIFFRACTION / 解像度: 1.22 Å

PDB-7fuy:
PanDDA analysis group deposition -- PHIP in complex with Z1284554279
手法: X-RAY DIFFRACTION / 解像度: 1.15 Å

PDB-7fuz:
PanDDA analysis group deposition -- PHIP in complex with Z4307421429
手法: X-RAY DIFFRACTION / 解像度: 1.43 Å

PDB-7fv0:
PanDDA analysis group deposition -- PHIP in complex with Z44602337
手法: X-RAY DIFFRACTION / 解像度: 1.21 Å

PDB-7fv1:
PanDDA analysis group deposition -- PHIP in complex with Z4912742920
手法: X-RAY DIFFRACTION / 解像度: 1.19 Å

PDB-7fv2:
PanDDA analysis group deposition -- PHIP in complex with Z445899798
手法: X-RAY DIFFRACTION / 解像度: 1.15 Å

PDB-7fv3:
PanDDA analysis group deposition -- PHIP in complex with Z4912742924
手法: X-RAY DIFFRACTION / 解像度: 1.15 Å

PDB-7fv4:
PanDDA analysis group deposition -- PHIP in complex with Z44602341
手法: X-RAY DIFFRACTION / 解像度: 1.15 Å

PDB-7fv5:
PanDDA analysis group deposition -- PHIP in complex with Z606695272
手法: X-RAY DIFFRACTION / 解像度: 1.15 Å

PDB-7fv6:
PanDDA analysis group deposition -- PHIP in complex with Z1334218055
手法: X-RAY DIFFRACTION / 解像度: 1.19 Å

PDB-7fv7:
PanDDA analysis group deposition -- PHIP in complex with Z1929967066
手法: X-RAY DIFFRACTION / 解像度: 1.25 Å

PDB-7fv8:
PanDDA analysis group deposition -- PHIP in complex with Z964297186
手法: X-RAY DIFFRACTION / 解像度: 1.15 Å

PDB-7fv9:
PanDDA analysis group deposition -- PHIP in complex with Z1004253138
手法: X-RAY DIFFRACTION / 解像度: 1.17 Å

PDB-7fva:
PanDDA analysis group deposition -- PHIP in complex with Z4913872963
手法: X-RAY DIFFRACTION / 解像度: 1.19 Å

PDB-7fvb:
PanDDA analysis group deposition -- PHIP in complex with Z6617539657
手法: X-RAY DIFFRACTION / 解像度: 1.38 Å

PDB-7fvc:
PanDDA analysis group deposition -- PHIP in complex with Z495704106
手法: X-RAY DIFFRACTION / 解像度: 1.18 Å

PDB-7fvd:
PanDDA analysis group deposition -- PHIP in complex with Z1424453050
手法: X-RAY DIFFRACTION / 解像度: 1.36 Å

PDB-7fve:
PanDDA analysis group deposition -- PHIP in complex with Z488932160
手法: X-RAY DIFFRACTION / 解像度: 1.19 Å

PDB-7fvf:
PanDDA analysis group deposition -- PHIP in complex with Z123605878
手法: X-RAY DIFFRACTION / 解像度: 1.15 Å

PDB-7fvg:
PanDDA analysis group deposition -- PHIP in complex with Z992453336
手法: X-RAY DIFFRACTION / 解像度: 1.15 Å

PDB-7fvh:
PanDDA analysis group deposition -- PHIP in complex with Z5067911819
手法: X-RAY DIFFRACTION / 解像度: 1.15 Å

PDB-7fvi:
PanDDA analysis group deposition -- PHIP in complex with Z183306756
手法: X-RAY DIFFRACTION / 解像度: 1.18 Å

PDB-7fvj:
PanDDA analysis group deposition -- PHIP in complex with Z4913873236
手法: X-RAY DIFFRACTION / 解像度: 1.19 Å

PDB-7fvk:
PanDDA analysis group deposition -- PHIP in complex with Z409964562
手法: X-RAY DIFFRACTION / 解像度: 1.15 Å

PDB-7fvl:
PanDDA analysis group deposition -- PHIP in complex with Z4140355932
手法: X-RAY DIFFRACTION / 解像度: 1.15 Å

PDB-7fvm:
PanDDA analysis group deposition -- PHIP in complex with Z1590917771
手法: X-RAY DIFFRACTION / 解像度: 1.26 Å

PDB-7fvn:
PanDDA analysis group deposition -- PHIP in complex with Z371875396
手法: X-RAY DIFFRACTION / 解像度: 1.15 Å

PDB-7fvo:
PanDDA analysis group deposition -- PHIP in complex with Z1435810807
手法: X-RAY DIFFRACTION / 解像度: 1.19 Å

PDB-7fvp:
PanDDA analysis group deposition -- PHIP in complex with Z1004277578
手法: X-RAY DIFFRACTION / 解像度: 1.15 Å

PDB-7fvq:
PanDDA analysis group deposition -- PHIP in complex with Z68576046
手法: X-RAY DIFFRACTION / 解像度: 1.15 Å

PDB-7fvr:
PanDDA analysis group deposition -- PHIP in complex with Z166737374
手法: X-RAY DIFFRACTION / 解像度: 1.19 Å

PDB-7g9k:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1262246195
手法: X-RAY DIFFRACTION / 解像度: 1.551 Å

PDB-7g9l:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z111782404
手法: X-RAY DIFFRACTION / 解像度: 1.541 Å

PDB-7g9m:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z44584886
手法: X-RAY DIFFRACTION / 解像度: 1.541 Å

PDB-7g9n:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z57821475
手法: X-RAY DIFFRACTION / 解像度: 1.422 Å

PDB-7g9o:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z133716556
手法: X-RAY DIFFRACTION / 解像度: 1.931 Å

PDB-7g9p:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1619958679
手法: X-RAY DIFFRACTION / 解像度: 1.743 Å

PDB-7g9q:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z751811134
手法: X-RAY DIFFRACTION / 解像度: 2.131 Å

PDB-7g9r:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z385450668
手法: X-RAY DIFFRACTION / 解像度: 1.798 Å

PDB-7g9s:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z758198920
手法: X-RAY DIFFRACTION / 解像度: 2.09 Å

PDB-7g9t:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z18618496
手法: X-RAY DIFFRACTION / 解像度: 1.904 Å

PDB-7g9u:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z55222357
手法: X-RAY DIFFRACTION / 解像度: 1.689 Å

PDB-7g9v:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z383202616
手法: X-RAY DIFFRACTION / 解像度: 1.74 Å

PDB-7g9w:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z444860982
手法: X-RAY DIFFRACTION / 解像度: 1.855 Å

PDB-7g9x:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z905065822
手法: X-RAY DIFFRACTION / 解像度: 1.809 Å

PDB-7g9y:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z2678251369
手法: X-RAY DIFFRACTION / 解像度: 1.83 Å

PDB-7g9z:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1216822028
手法: X-RAY DIFFRACTION / 解像度: 1.622 Å

PDB-7ga0:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z2048325751
手法: X-RAY DIFFRACTION / 解像度: 1.967 Å

PDB-7ga1:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with POB0128
手法: X-RAY DIFFRACTION / 解像度: 2.093 Å

PDB-7ga2:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with POB0008
手法: X-RAY DIFFRACTION / 解像度: 2.034 Å

PDB-7ga3:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z3241250482
手法: X-RAY DIFFRACTION / 解像度: 1.809 Å

PDB-7ga4:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z56823075
手法: X-RAY DIFFRACTION / 解像度: 1.749 Å

PDB-7ga5:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z119989094
手法: X-RAY DIFFRACTION / 解像度: 1.843 Å

PDB-7ga6:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1509711879
手法: X-RAY DIFFRACTION / 解像度: 1.749 Å

PDB-7ga7:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z85933875
手法: X-RAY DIFFRACTION / 解像度: 1.42 Å

PDB-7ga8:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z1198158918
手法: X-RAY DIFFRACTION / 解像度: 1.87 Å

PDB-7ga9:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z1198177230
手法: X-RAY DIFFRACTION / 解像度: 2.17 Å

PDB-7gaa:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z1198233191
手法: X-RAY DIFFRACTION / 解像度: 2.03 Å

PDB-7gab:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z1255402624
手法: X-RAY DIFFRACTION / 解像度: 2.23 Å

PDB-7gac:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z1456069604
手法: X-RAY DIFFRACTION / 解像度: 1.91 Å

PDB-7gad:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z1667545918
手法: X-RAY DIFFRACTION / 解像度: 1.86 Å

PDB-7gae:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z1688504114
手法: X-RAY DIFFRACTION / 解像度: 1.92 Å

PDB-7gaf:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z183352334
手法: X-RAY DIFFRACTION / 解像度: 1.84 Å

PDB-7gag:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z198195770
手法: X-RAY DIFFRACTION / 解像度: 1.59 Å

PDB-7gah:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z2033637875
手法: X-RAY DIFFRACTION / 解像度: 1.9 Å

PDB-7gai:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z212122838
手法: X-RAY DIFFRACTION / 解像度: 1.97 Å

PDB-7gaj:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z285233820
手法: X-RAY DIFFRACTION / 解像度: 1.89 Å

PDB-7gak:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z287121492
手法: X-RAY DIFFRACTION / 解像度: 1.77 Å

PDB-7gal:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z291279160
手法: X-RAY DIFFRACTION / 解像度: 1.91 Å

PDB-7gam:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z373768900
手法: X-RAY DIFFRACTION / 解像度: 1.75 Å

PDB-7gan:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z56767614
手法: X-RAY DIFFRACTION / 解像度: 2.09 Å

PDB-7gao:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z57450788
手法: X-RAY DIFFRACTION / 解像度: 1.69 Å

PDB-7gap:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z728939702
手法: X-RAY DIFFRACTION / 解像度: 1.68 Å

PDB-7gaq:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z755044716
手法: X-RAY DIFFRACTION / 解像度: 2.14 Å

PDB-7gar:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z820676436
手法: X-RAY DIFFRACTION / 解像度: 2.07 Å

PDB-7gas:
PanDDA analysis group deposition -- Crystal Structure of MAP1LC3B in complex with Z952016136
手法: X-RAY DIFFRACTION / 解像度: 1.91 Å

PDB-7hi8:
PanDDA analysis group deposition -- Crystal Structure of ground state model of human Brachyury
手法: X-RAY DIFFRACTION / 解像度: 1.54 Å

化合物

ChemComp-MLI:
MALONATE ION / マロナ-ト

ChemComp-NI:
NICKEL (II) ION

ChemComp-9KS:
N-(2-hydroxyphenyl)acetamide / N-(2-ヒドロキシフェニル)アセトアミド

ChemComp-HOH:
WATER

ChemComp-AW7:
2-[4-(1~{H}-pyrazol-3-yl)phenoxy]pyrimidine

ChemComp-AWA:
(6~{R})-6-(4-methoxyphenyl)-2-oxidanylidene-5,6-dihydro-1~{H}-pyrimidine-4-carboxylic acid

ChemComp-AWD:
~{N}-(4-fluorophenyl)-4-methyl-piperazine-1-carboxamide / N-(4-フルオロフェニル)-4-メチル-1-ピペラジンカルボアミド

ChemComp-AWG:
~{N}2-(1~{H}-benzimidazol-2-yl)benzene-1,2-diamine

ChemComp-AWM:
2-(4-methylpiperazin-1-yl)-1,3-benzothiazole / 1-(2-ベンゾチアゾリル)-4-メチルピペラジン

ChemComp-AWP:
1-cyclohexyl-3-(2-pyridin-4-ylethyl)urea

ChemComp-AWS:
8-[(dimethylamino)methyl]-4-methyl-7-oxidanyl-chromen-2-one

ChemComp-AWV:
3-(azepan-1-ylmethyl)-1~{H}-indole

ChemComp-AWY:
~{N}-[2-(7-methoxynaphthalen-1-yl)ethyl]ethanamide / アゴメラチン / 抗うつ薬*YM

ChemComp-AXG:
1-(phenylmethyl)-4-pyrrol-1-yl-piperidine / 1-(1-ベンジル-4-ピペリジニル)-1H-ピロ-ル

ChemComp-AXJ:
[(2~{R})-1-[[(1~{R},5~{S})-6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methyl]pyrrolidin-2-yl]methanol

ChemComp-AXS:
1-(4-fluorophenyl)-~{N}-[[(2~{R})-oxolan-2-yl]methyl]methanamine

ChemComp-AXV:
1~{H}-benzimidazol-2-ylcyanamide

ChemComp-AY4:
2,4-bis(fluoranyl)-6-(1~{H}-pyrazol-3-yl)phenol

ChemComp-AYJ:
2-[cyclohexyl(methylsulfonyl)amino]ethanamide

ChemComp-AYS:
2-[(4-chlorophenyl)amino]benzamide

ChemComp-AYV:
1-[2-methyl-1,3-bis(oxidanyl)propan-2-yl]-3-phenyl-urea

ChemComp-B0A:
~{N}-cyclohexyl-2-phenoxy-ethanamide

ChemComp-B0G:
(phenylmethyl) 4-oxidanylpiperidine-1-carboxylate / 4-ヒドロキシピペリジン-1-カルボン酸ベンジル

ChemComp-B0J:
4-[[[(4~{S})-2,2-dimethyloxan-4-yl]amino]methyl]phenol

ChemComp-B0M:
1~{H}-indol-6-yl-(4-methylpiperazin-1-yl)methanone

ChemComp-B0V:
2-methoxy-~{N}-(2,4,6-trimethylphenyl)ethanamide

ChemComp-DMS:
DIMETHYL SULFOXIDE / 2-チアプロパン2-オキシド / DMSO, 沈殿剤*YM

ChemComp-B0Y:
5-ethyl-~{N}-[(1-methylpyrazol-4-yl)methyl]thiophene-2-carboxamide

ChemComp-B1A:
~{N}-(4-phenylazanylphenyl)ethanamide / 4′-(アニリノ)アセトアニリド

ChemComp-B1J:
[1-(4-chlorophenyl)-1,2,3-triazol-4-yl]methanol

ChemComp-ACT:
ACETATE ION / 酢酸イオン

ChemComp-H3D:
N-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)cyclopentyl]acetamide

ChemComp-CL:
Unknown entry / クロリド

ChemComp-GQY:
2-methoxy-4-morpholin-4-yl-aniline / 2-メトキシ-4-(4-モルホリニル)アニリン

ChemComp-GV1:
~{N},~{N},5,6-tetramethylthieno[2,3-d]pyrimidin-4-amine

ChemComp-GV7:
4-[(5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)amino]phenol

ChemComp-GVY:
4-(5-amino-1,3,4-thiadiazol-2-yl)phenol

ChemComp-GW1:
(4-chloranyl-2-methyl-pyrazol-3-yl)-piperidin-1-yl-methanone

ChemComp-MG:
Unknown entry / マグネシウムジカチオン

ChemComp-K0G:
N-phenyl-N'-pyridin-3-ylurea / 1-(3-ピリジル)-3-フェニル尿素

ChemComp-EDO:
1,2-ETHANEDIOL / エチレングリコ-ル

ChemComp-PEG:
DI(HYDROXYETHYL)ETHER / ジエチレングリコ-ル

ChemComp-LD4:
N-cycloheptylpyrimidin-2-amine

ChemComp-JG4:
2-(thiophen-2-yl)-1H-imidazole / 2-(2-チエニル)-1H-イミダゾ-ル

ChemComp-JGP:
(azepan-1-yl)(2H-1,3-benzodioxol-5-yl)methanone

ChemComp-LDV:
3-[(4-methylpiperidin-1-yl)methyl]-1H-indole / 3-(4-メチルピペリジノメチル)-1H-インド-ル

ChemComp-LDS:
N-(4-ethoxyphenyl)pyrazine-2-carboxamide

ChemComp-LDJ:
2-methyl-N-{5-[(2S)-oxolan-2-yl]-1,3,4-thiadiazol-2(3H)-ylidene}propanamide

ChemComp-LDD:
(azepan-1-yl)(4-methoxyphenyl)methanone

ChemComp-LD7:
3-ethyl-N-[(4-fluorophenyl)methyl]-1,2,4-oxadiazole-5-carboxamide

ChemComp-LEY:
N-[(4-fluorophenyl)methyl]-2-(propan-2-yl)-1H-imidazole-5-carboxamide

ChemComp-LES:
(3S)-N-(pyrimidin-2-yl)azepan-3-amine

ChemComp-LEJ:
1-(difluoromethyl)-N-[(4-fluorophenyl)methyl]-1H-pyrazole-3-carboxamide

ChemComp-LE7:
N-[(4-fluorophenyl)methyl]-3-propyl-1H-pyrazole-5-carboxamide

ChemComp-LE4:
[2-(cycloheptylamino)pyrimidin-4-yl]methanol

ChemComp-LFP:
5-chloro-N-[(4-fluorophenyl)methyl]-1-methyl-1H-pyrazole-4-carboxamide

ChemComp-LFM:
N-[(4-fluorophenyl)methyl]-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-3-carboxamide

ChemComp-LFJ:
1-[4-(2H-1,3-benzodioxole-5-carbonyl)-2,3,4,5-tetrahydro-1H-1,4-diazepin-1-yl]ethan-1-one

ChemComp-LFG:
N-cycloheptyl-5-cyclopropyl-1,3,4-oxadiazol-2-amine

ChemComp-LF4:
N-[(4-fluorophenyl)methyl]-3-(propan-2-yl)-1H-pyrazole-5-carboxamide

ChemComp-LJ7:
N-[(4-fluorophenyl)methyl]-1-(propan-2-yl)-1H-pyrazole-3-carboxamide

ChemComp-LHS:
N-[(4-fluorophenyl)methyl]-5-(methoxymethyl)-1,2,4-oxadiazole-3-carboxamide

ChemComp-LHM:
N-[(4-fluorophenyl)methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine-3-carboxamide

ChemComp-LH7:
1-[(3S)-1,1-dioxo-1lambda~6~-thiolan-3-yl]-N-[(4-fluorophenyl)methyl]-5-methyl-1H-pyrazole-4-carboxamide

ChemComp-LFY:
1-ethyl-N-[(4-fluorophenyl)methyl]-1H-imidazole-4-carboxamide

ChemComp-LJM:
5-ethyl-N-[(4-fluorophenyl)methyl]-1,3-thiazole-2-carboxamide

ChemComp-LJJ:
N-cycloheptyl-5-methyl-1,3,4-oxadiazol-2-amine

ChemComp-LJD:
N-[(4-chlorophenyl)methyl]-1-methyl-1H-pyrazole-4-carboxamide

ChemComp-JH1:
1-ethyl-N-[(4-fluorophenyl)methyl]-1H-pyrazole-4-carboxamide

ChemComp-LJA:
N-[3-(carbamoylamino)phenyl]acetamide

ChemComp-JGA:
N-ethyl-N'-(5-methyl-1,2-oxazol-3-yl)urea

ChemComp-N5S:
N-(5-methyl-1,2-oxazol-3-yl)-N'-[(3S)-4,4,4-trifluoro-3-hydroxy-3-(5-methylfuran-2-yl)butyl]urea

ChemComp-N5V:
N-ethyl-N'-1,3-thiazol-2-ylurea

ChemComp-N64:
N-(5-methyl-1,2-oxazol-3-yl)-N'-[3-(4-phenylpiperazin-1-yl)propyl]urea

ChemComp-N67:
N-methyl-5-({[(5-methyl-1,2-oxazol-3-yl)carbamoyl]amino}methyl)thiophene-2-sulfonamide

ChemComp-N6D:
N-[3-(methoxymethyl)phenyl]-N'-(5-methyl-1,2-oxazol-3-yl)urea

ChemComp-N6J:
N-{1-[(imidazo[1,2-a]pyridin-2-yl)methyl]-1H-pyrazol-4-yl}-N'-(5-methyl-1,2-oxazol-3-yl)urea

ChemComp-N6V:
N-{1-[2-(diethylamino)ethyl]-1H-indol-5-yl}-N'-(5-methyl-1,2-oxazol-3-yl)urea

ChemComp-N71:
N-(5-methyl-1,2-oxazol-3-yl)-N'-[2-(phenylsulfonyl)ethyl]urea

ChemComp-N74:
N-(1-benzyl-1H-pyrazol-4-yl)-N'-(5-methyl-1,2-oxazol-3-yl)urea

ChemComp-N5D:
N-cyclopropyl-2-(4-{[(5-methyl-1,2-oxazol-3-yl)carbamoyl]amino}-1H-pyrazol-1-yl)acetamide

ChemComp-PLP:
PYRIDOXAL-5'-PHOSPHATE / ピリドキサ-ル5′-りん酸

ChemComp-NSJ:
3-[(thiomorpholin-4-yl)methyl]phenol

ChemComp-NSV:
1-[(2-methyl-1,3-thiazol-5-yl)methyl]piperazine

ChemComp-JHP:
4-chloro-N-cyclopentyl-1-methyl-1H-pyrazole-3-carboxamide

ChemComp-NT7:
N-(2,3-dimethylphenyl)-2-(morpholin-4-yl)acetamide

ChemComp-NTG:
5-(1,4-oxazepan-4-yl)pyridine-2-carbonitrile

ChemComp-NTV:
(2S)-N-(3-chloro-2-methylphenyl)oxolane-2-carboxamide

ChemComp-NU4:
2-methyl-N-(pyridin-4-yl)furan-3-carboxamide

ChemComp-NUA:
N-(1-ethyl-1H-pyrazol-4-yl)cyclobutanecarboxamide

ChemComp-NUG:
1-[(2,5-dihydrothiophen-3-yl)methyl]piperidin-4-ol

ChemComp-NUJ:
trans-3-[(2,6-dimethylpyrimidin-4-yl)(methyl)amino]cyclobutan-1-ol

ChemComp-NUM:
N-[2-(4-hydroxyphenyl)ethyl]pyridine-2-carboxamide

ChemComp-HR5:
~{N}-(cyclobutylmethyl)-1,5-dimethyl-pyrazole-4-carboxamide

ChemComp-JO1:
1-methyl-N-[(thiophen-2-yl)methyl]-1H-pyrazole-5-carboxamide

ChemComp-NUY:
[4-(propan-2-yl)piperazin-1-yl](thiophen-2-yl)methanone

ChemComp-NV7:
1-[(furan-2-yl)methyl]-4-(methylsulfonyl)piperazine

ChemComp-K0V:
methyl 1-(tert-butylcarbamoyl)piperidine-4-carboxylate

ChemComp-LUY:
~{N}-(2-phenylethyl)-1~{H}-benzimidazol-2-amine

ChemComp-NVD:
N-{[4-(dimethylamino)phenyl]methyl}-4H-1,2,4-triazol-4-amine

ChemComp-NVJ:
ethyl benzylcarbamate / ベンジルカルバミド酸エチル

ChemComp-NVM:
[(4R)-4-methyl-2,3,4,5-tetrahydro-1H-azepin-1-yl](1,3-thiazol-4-yl)methanone

ChemComp-NVY:
1-ethyl-N-(2-fluorophenyl)piperidin-4-amine

ChemComp-NW4:
3-cyclohexyl-1-(morpholin-4-yl)propan-1-one

ChemComp-J4Q:
4-[(2-methylsulfonylimidazol-1-yl)methyl]-1,3-thiazole

ChemComp-NW7:
3-ethyl-5-methyl-N-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole-4-carboxamide

ChemComp-CD:
Unknown entry

ChemComp-JMM:
[4-(cyclopropanecarbonyl)piperazin-1-yl](furan-2-yl)methanone

ChemComp-NWP:
(2R)-N,2-dimethyl-N-(propan-2-yl)morpholine-4-sulfonamide

ChemComp-NWV:
N-[(1-methyl-1H-pyrazol-4-yl)methyl]furan-2-carboxamide

ChemComp-NWY:
N-[(6-methylpyridin-3-yl)methyl]cyclobutanecarboxamide

ChemComp-K1A:
3-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-5-methyl-1,3,4-thiadiazol-2(3H)-one

ChemComp-NX7:
(2,6-difluorophenyl)(pyrrolidin-1-yl)methanone

ChemComp-NXJ:
(1S)-N,2,2-trimethyl-N-(pyridin-3-yl)cyclopropane-1-carboxamide

ChemComp-NXM:
4-[(3-cyclopropyl-1,2,4-oxadiazol-5-yl)methyl]piperidine

ChemComp-NXS:
[1-(pyrimidin-2-yl)piperidin-4-yl]methanol

ChemComp-NY1:
2-(2-methyl-1,3-thiazol-4-yl)-1-(morpholin-4-yl)ethan-1-one

ChemComp-NY4:
N-{4-[(1S)-1-aminoethyl]phenyl}cyclopropanecarboxamide

ChemComp-GWA:
~{N}-(3-acetamidophenyl)-2-methoxy-ethanamide

ChemComp-NY7:
N-(2-methoxy-5-methylphenyl)glycinamide

ChemComp-K2M:
4-(furan-2-carbonyl)piperazine-1-carboxamide

ChemComp-NYV:
1-(propan-2-yl)-1H-imidazole-4-sulfonamide

ChemComp-NZG:
3-(acetylamino)-4-fluorobenzoic acid

ChemComp-NZD:
4-methyl-N-phenylpiperazine-1-carboxamide / 4-メチル-N-フェニルピペラジン-1-カルボアミド

ChemComp-NZ7:
(5R)-N,N-dimethyl-2,9-dioxa-6-azaspiro[4.5]decane-6-carboxamide

ChemComp-NZ4:
N-(3-acetylphenyl)morpholine-4-carboxamide

ChemComp-NZ1:
5-methoxy-1,3-benzothiazol-2-amine / 5-メトキシベンゾチアゾ-ル-2-アミン

ChemComp-LV4:
1-[2-(trifluoromethyloxy)phenyl]thiourea

ChemComp-JFP:
N-(4-methyl-1,3-thiazol-2-yl)propanamide

ChemComp-NZJ:
1-(3-methylbenzene-1-carbonyl)piperidine-4-carboxamide

ChemComp-O0G:
(2S)-2-[(5-chloro-3-fluoropyridin-2-yl)amino]propan-1-ol

ChemComp-O0J:
N-[4-(2-amino-1,3-thiazol-4-yl)phenyl]acetamide

ChemComp-K2P:
2-(trifluoromethoxy)benzoic acid / 2-(トリフルオロメトキシ)安息香酸

ChemComp-O0M:
1-{[4-(propan-2-yl)phenyl]methyl}piperidin-4-ol

ChemComp-O0P:
N-[(3-fluorophenyl)methyl]-N-methylsulfuric diamide

ChemComp-O0S:
N-{4-[(pyrimidin-2-yl)oxy]phenyl}acetamide

ChemComp-O0V:
(2S)-2-[(3-fluoropyridin-2-yl)(methyl)amino]propan-1-ol

ChemComp-O0Y:
3-(diethylamino)phenol / 3-(ジエチルアミノ)フェノ-ル

ChemComp-O1A:
N-[4-(4-methylpiperazin-1-yl)phenyl]acetamide / N-[4-(4-メチルピペラジノ)フェニル]アセトアミド

ChemComp-O1D:
3-(benzyloxy)aniline / 3-(ベンジルオキシ)アニリン

ChemComp-O1M:
4-(4-fluorophenyl)piperazine-1-carboxamide

ChemComp-O1J:
(benzyloxy)acetic acid / ベンジルオキシ酢酸

ChemComp-O2A:
N-methyl-1H-indole-7-carboxamide

ChemComp-O2D:
2-cyclohexyl-N-(4H-1,2,4-triazol-4-yl)acetamide

ChemComp-O2J:
(2R)-2-(methoxymethyl)-4-(pyridin-2-yl)morpholine

ChemComp-O2M:
N-[(4-methyl-1,3-thiazol-2-yl)methyl]-1H-pyrazole-5-carboxamide

ChemComp-LVV:
4-[(4-methylphenyl)methyl]-1,4-thiazinane 1,1-dioxide

ChemComp-O2P:
N-(2-hydroxy-4-methylphenyl)-2-methylbenzamide

ChemComp-O3A:
(3S)-N-methyl-N-phenylpyrrolidine-3-carboxamide

ChemComp-O3D:
4-[(furan-2-yl)methyl]-1lambda~6~,4-thiazinane-1,1-dione

ChemComp-O3G:
N-benzyl-1-(4-fluorophenyl)methanamine / ベンジル(4-フルオロベンジル)アミン

ChemComp-O3J:
1-[4-(3-phenylpropyl)piperazin-1-yl]ethan-1-one / 1-[4-(3-フェニルプロピル)ピペラジン-1-イル]エタノン

ChemComp-O3M:
4-[(3,4-dihydroisoquinolin-2(1H)-yl)methyl]phenol

ChemComp-K0J:
N-ethyl-1H-1,2,3-triazole-4-carboxamide

ChemComp-K3J:
N-ethyl-6-methylpyridazin-3-amine

ChemComp-JHJ:
N-(4-methoxyphenyl)-N'-pyridin-4-ylurea / 1-[(4-メトキシフェニル)]-3-(ピリジン-4-イル)尿素

ChemComp-DSJ:
1-(4-amino-2-hydroxyphenyl)ethan-1-one / 4′-アミノ-2′-ヒドロキシアセトフェノン

ChemComp-UNX:
Unknown entry

ChemComp-SO4:
SULFATE ION / 硫酸ジアニオン

ChemComp-PW7:
4-(trifluoromethyl)pyrimidin-2-amine / 4-(トリフルオロメチル)ピリミジン-2-アミン

ChemComp-PWA:
7-fluoroquinazolin-4(3H)-one / 7-フルオロキナゾリン-4(3H)-オン

ChemComp-PWD:
5-fluoro-1H-pyrrolo[2,3-b]pyridine

ChemComp-PWG:
3-(difluoromethyl)-8-(trifluoromethyl)[1,2,4]triazolo[4,3-a]pyridine

ChemComp-PWJ:
8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridine-7-carbonitrile

ChemComp-PWM:
5-fluoroquinazolin-4(3H)-one / 5-フルオロキナゾリン-4(3H)-オン

ChemComp-PWP:
6-fluoroquinazolin-4(3H)-one / 6-フルオロキナゾリン-4-オ-ル

ChemComp-PWS:
3-methyl-2-(methylsulfanyl)-6-(trifluoromethyl)pyrimidin-4(3H)-one

ChemComp-RU4:
4-(1,2,3-thiadiazol-4-yl)phenyl ethylcarbamate

ChemComp-TRS:
2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL / トリス(ヒドロキシメチル)メチルアンモニウム / pH緩衝剤*YM

ChemComp-HWH:
~{N}-[2-(5-fluoranyl-1~{H}-indol-3-yl)ethyl]ethanamide / N-[2-(5-フルオロ-1H-インド-ル-3-イル)エチル]アセトアミド

ChemComp-RUV:
4-(acetylamino)-N-(4H-1,2,4-triazol-4-yl)benzamide

ChemComp-RUY:
4-(piperidin-1-yl)-1,2,5-oxadiazol-3-amine

ChemComp-RV4:
N-{4-[(morpholin-4-yl)methyl]phenyl}acetamide

ChemComp-M25:
N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE / DK-42

ChemComp-K3D:
4-acetyl-N-ethylpiperazine-1-carboxamide

ChemComp-ZN:
Unknown entry

ChemComp-RVY:
(5S)-5-methyl-5-[(1-phenyl-1H-1,2,3-triazol-4-yl)methyl]pyrrolidine-2,4-dione

ChemComp-RW7:
(3S)-3,4-dimethyl-3-propyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione

ChemComp-RWA:
(5R)-3,3,5-trimethyl-5-[(1-phenyl-1H-1,2,3-triazol-4-yl)methyl]pyrrolidine-2,4-dione

ChemComp-RWD:
(4S,5R)-4-hydroxy-5-methyl-5-[(1-phenyl-1H-1,2,3-triazol-4-yl)methyl]pyrrolidin-2-one

ChemComp-RWG:
(5R)-5-{[1-(4-fluorophenyl)-1H-1,2,3-triazol-4-yl]methyl}-5-methylpyrrolidine-2,4-dione

ChemComp-RWM:
(5S)-5-methyl-5-[(3-phenyl-1,2-oxazol-5-yl)methyl]pyrrolidine-2,4-dione

ChemComp-RY4:
N-[4-(aminomethyl)phenyl]methanesulfonamide

ChemComp-GQJ:
methyl (2~{S},4~{R})-1-(furan-2-ylcarbonyl)-4-oxidanyl-pyrrolidine-2-carboxylate

ChemComp-RYG:
~{N}-[(3~{R})-2-oxidanylideneazepan-3-yl]furan-2-carboxamide

ChemComp-RYM:
4-(benzimidazol-1-ylmethyl)benzenecarbonitrile / 4-(1H-ベンゾイミダゾ-ル-1-イルメチル)ベンゾニトリル

ChemComp-RYP:
~{N}-methyl-1-pyridin-4-yl-methanamine / N-メチルピリジン-4-メタンアミン

ChemComp-S07:
2-(2,4-dimethylphenoxy)-1-morpholin-4-yl-ethanone

ChemComp-S0P:
~{N}-(4-cyanophenyl)ethanamide / N-(4-シアノフェニル)アセトアミド

ChemComp-S0S:
(3~{R},4~{R})-1,1-bis(oxidanylidene)-4-(pyridin-3-ylmethylamino)thiolan-3-ol

ChemComp-6SU:
methyl 3-(methylsulfonylamino)benzoate / 3-(メチルスルホニルアミノ)安息香酸メチル

ChemComp-S0V:
morpholin-4-yl(1,2,3-thiadiazol-4-yl)methanone

ChemComp-S1G:
4-[(phenylmethyl)amino]benzoic acid / 4-(ベンジルアミノ)安息香酸

ChemComp-GQP:
1-[(4-fluorophenyl)methyl]benzimidazole / 1-(4-フルオロベンジル)-1H-ベンゾイミダゾ-ル

ChemComp-S1J:
3-azanyl-4-(pyridin-3-ylmethylamino)benzoic acid

ChemComp-N08:
~{N}-[2-(4-fluorophenyl)ethyl]furan-2-carboxamide

ChemComp-S1M:
methyl 2-[(2~{S})-1-ethanoyl-3-oxidanylidene-piperazin-2-yl]ethanoate

ChemComp-JOV:
3-chloro-N-(1-hydroxy-2-methylpropan-2-yl)benzamide

ChemComp-S1V:
1-ethanoylpiperidine-4-carbonitrile

ChemComp-MH5:
3-[(5-methylthiophen-2-yl)methylamino]benzoic acid

ChemComp-S2J:
methyl 2-[(2~{R})-1-(ethylcarbamoyl)-3-oxidanylidene-piperazin-2-yl]ethanoate

ChemComp-S2S:
4-(methylsulfonylamino)benzamide / 4-[(メチルスルホニル)アミノ]ベンズアミド

ChemComp-S2V:
(1-methylpiperidin-4-yl) 3-fluoranylbenzoate

ChemComp-V3J:
(4,7-dihydro-2H-1lambda~4~,2,3-benzothiadiazol-5-yl)(morpholin-4-yl)methanone

ChemComp-S2Y:
~{N}-[(4-fluorophenyl)methyl]-4-methoxy-aniline / N-(4-フルオロベンジル)-4-メトキシアニリン

ChemComp-7MU:
4-chloranyl-~{N}-methyl-pyridine-2-carboxamide / N-メチル-4-クロロピリジン-2-カルボアミド

ChemComp-S34:
2-cyano-~{N}-(pyridin-4-ylmethyl)ethanamide

ChemComp-RWS:
1-(5-methyl-1,3,4-thiadiazol-2-yl)piperidine

ChemComp-EJQ:
~{N}-(4-fluorophenyl)-2-pyrrolidin-1-yl-ethanamide

ChemComp-RWV:
1-{1-[(2-methyl-1,3-thiazol-4-yl)methyl]piperidin-4-yl}methanamine

ChemComp-JGG:
N-[(4-cyanophenyl)methyl]morpholine-4-carboxamide

ChemComp-RX7:
2-methyl-2-{[(3-methylthiophen-2-yl)methyl]amino}propan-1-ol

ChemComp-RXG:
2-(4-fluorophenoxy)-1-(1H-pyrrol-1-yl)ethan-1-one

ChemComp-K1P:
1-(3-methyl-1,2,4-thiadiazol-5-yl)-1,4-diazepane

ChemComp-RXJ:
4-(4-methylpiperazin-1-yl)benzonitrile / 4-(4-メチルピペラジノ)ベンゾニトリル

ChemComp-RXS:
3-[(2-methyl-1H-imidazol-1-yl)methyl]benzonitrile

ChemComp-M0J:
N-[(2S)-2-hydroxypropyl]-N'-phenylurea

ChemComp-K0Y:
methyl N-(5-methyl-1,2-oxazole-3-carbonyl)glycinate

ChemComp-S6V:
1-[2-(2-oxidanylidenepyrrolidin-1-yl)ethyl]-3-phenyl-urea

ChemComp-PO4:
PHOSPHATE ION / ホスファ-ト

ChemComp-MPD:
(4S)-2-METHYL-2,4-PENTANEDIOL / (S)-2-メチル-2,4-ペンタンジオ-ル / 沈殿剤*YM

ChemComp-UQJ:
3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide / 3-(ジフルオロメチル)-1-メチル-1H-ピラゾ-ル-4-カルボアミド

ChemComp-T6J:
2-[(methylsulfonyl)methyl]-1H-benzimidazole / 2-(メチルスルホニルメチル)-1H-ベンゾイミダゾ-ル

ChemComp-UQM:
N-[4-(2-amino-2-oxoethyl)phenyl]acetamide

ChemComp-H04:
1-(2-ethoxyphenyl)piperazine / 1-(2-エトキシフェニル)ピペラジン

ChemComp-UQS:
N-[(2-fluorophenyl)methyl]-1H-pyrazol-4-amine

ChemComp-UQV:
[2-(acetylamino)phenyl]acetic acid

ChemComp-7ZC:
1-(5-methoxy-1H-indol-3-yl)-N,N-dimethyl-methanamine / 5-メトキシグラミン

ChemComp-JFS:
[4-(1H-benzimidazol-1-yl)phenyl]methanol

ChemComp-UQY:
1-(methylamino)cyclopentane-1-carboxamide

ChemComp-UR7:
1-(3-fluoro-4-methylphenyl)methanesulfonamide

ChemComp-UR4:
2-methoxy-N-(4-phenyl-1,3-thiazol-2-yl)acetamide

ChemComp-UR1:
3-fluoro-5-methylbenzene-1-sulfonamide

ChemComp-T1J:
2-{[(1H-benzimidazol-2-yl)amino]methyl}phenol / 2-[(1H-ベンゾイミダゾ-ル-2-イルアミノ)メチル]フェノ-ル

ChemComp-WGA:
(3S)-1-(3-fluoropyridin-2-yl)-4,4-dimethylpyrrolidin-3-ol

ChemComp-WGD:
1-{(2S,4S)-4-fluoro-1-[(2-methyl-1,3-thiazol-4-yl)methyl]pyrrolidin-2-yl}methanamine

ChemComp-2L1:
2-[(4-methyl-1H-imidazol-5-yl)methyl]-1,2,3,4-tetrahydroisoquinoline

ChemComp-U0M:
5-fluoro-1-[(5-methyl-1,3,4-thiadiazol-2-yl)methyl]-1,2,3,6-tetrahydropyridine

ChemComp-I81:
1-[(3-methoxyphenyl)methyl]piperidine-4-carboxamide

ChemComp-I87:
(2S)-N,2-dimethyl-N-(propan-2-yl)morpholine-4-sulfonamide

ChemComp-I8A:
N-(cyclopropylmethyl)-2,2,3,3-tetramethylazetidine-1-carboxamide

ChemComp-I8D:
(4-chlorophenyl)(thiomorpholin-4-yl)methanone

ChemComp-I8G:
2-(4-fluorophenoxy)-1-(pyrrolidin-1-yl)ethan-1-one

ChemComp-I8J:
5-fluoro-1-(1-methylcyclopropane-1-sulfonyl)-1,2,3,6-tetrahydropyridine

ChemComp-I8M:
2-[(morpholin-4-yl)methyl]phenol / 2-(モルホリノメチル)フェノ-ル

ChemComp-LF6:
{(1R,2R)-2-[(Z)-(3-methyl-1,2,4-thiadiazol-5(2H)-ylidene)amino]cyclopentyl}methanol

ChemComp-LFO:
N,1-dimethyl-1H-indole-3-carboxamide / N-メチル-1-メチル-1H-インド-ル-3-カルボアミド

ChemComp-LGR:
2-[acetyl(methyl)amino]benzoic acid / 2-(アセチルメチルアミノ)安息香酸

ChemComp-LHR:
N-(1H-indazol-6-yl)acetamide

ChemComp-WNV:
N,N,2,3-tetramethylbenzamide

ChemComp-60P:
3-methylthiophene-2-carboxylic acid / 3-メチルチオフェン-2-カルボン酸

ChemComp-W0G:
(3R)-1-(2-fluorophenyl)-3-(methylamino)pyrrolidin-2-one

ChemComp-LJR:
1-cyclohexyl-N-methylmethanesulfonamide

ChemComp-LJK:
3-methyl-N-(2-methylbutan-2-yl)-1H-pyrazole-5-carboxamide

ChemComp-U1V:
1-(4-fluoro-2-methylphenyl)methanesulfonamide

ChemComp-LJ6:
(2R)-3-(3,5-dimethyl-1,2-oxazol-4-yl)-N,N,2-trimethylpropanamide

ChemComp-LLU:
(2S)-2-(2-fluorophenoxy)propanoic acid / (S)-2-(2-フルオロフェノキシ)プロパン酸

ChemComp-LL0:
2-(difluoromethoxy)benzene-1-sulfonamide

ChemComp-LKU:
3-fluoro-N-(3-hydroxy-4-methylphenyl)benzamide

ChemComp-LKL:
2-[(5-chloro-3-fluoropyridin-2-yl)(methyl)amino]ethan-1-ol

ChemComp-LK6:
N-[(3R)-3-methyl-1,1-dioxo-1lambda~6~-thiolan-3-yl]cyclopropanecarboxamide

ChemComp-WN1:
N-(2-fluorophenyl)-3-methoxybenzamide

ChemComp-JJM:
1-methyl-N-(3-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

ChemComp-UWY:
N-(1-ethyl-1H-pyrazol-4-yl)cyclopentanecarboxamide

ChemComp-ELQ:
[3,4-bis(fluoranyl)phenyl]-(4-methylpiperazin-1-yl)methanone

ChemComp-LO6:
2-(difluoromethoxy)-1-[(2R,6S)-2,6-dimethylmorpholin-4-yl]ethan-1-one

ChemComp-SZE:
4-(3-fluoranylpyridin-2-yl)-1-methyl-piperazin-2-one

ChemComp-LNS:
6-(methylcarbamoyl)pyridine-2-carboxylic acid / 6-(メチルカルバモイル)-2-ピリジンカルボン酸

ChemComp-UX1:
1-[(2-fluorophenyl)methyl]-N-methylcyclopropane-1-carboxamide

ChemComp-U0V:
2-fluoro-N-[2-(pyridin-4-yl)ethyl]benzamide

ChemComp-LMW:
2-[(4-aminophenyl)(ethyl)amino]ethan-1-ol / 2-[(4-アミノフェニル)エチルアミノ]エタノ-ル

ChemComp-LM6:
1-(1-ethyl-1H-pyrazol-5-yl)-N-methylmethanamine

ChemComp-LQP:
2-(difluoromethoxy)-1-[(3aR,6aS)-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]ethan-1-one

ChemComp-LQI:
(1-benzofuran-2-yl)(4-methylpiperidin-1-yl)methanone

ChemComp-WH1:
N-methyl-N-[2-(pyridin-2-yl)ethyl]benzamide

ChemComp-LQ3:
(5S)-5-(difluoromethoxy)pyridin-2(5H)-one

ChemComp-GT4:
~{N}-(4-hydroxyphenyl)-2-methoxy-ethanamide

ChemComp-S5J:
2-[4-(2-methoxyphenyl)piperazin-1-yl]ethanenitrile

ChemComp-LPU:
1-(methanesulfonyl)piperidin-4-ol

ChemComp-WKA:
N-(2,1,3-benzoxadiazol-4-yl)acetamide / N-(ベンゾフラザン-4-イル)アセトアミド

ChemComp-VZS:
N-(2-methoxy-5-methylphenyl)-N'-4H-1,2,4-triazol-4-ylurea

ChemComp-LRR:
1-(morpholin-4-yl)-4-phenylbutan-1-one / 4-(4-フェニルブチリル)モルホリン

ChemComp-LRF:
N~2~-(4-cyano-3-methyl-1,2-thiazol-5-yl)-N~2~-methylglycinamide

ChemComp-WKS:
2,4-dimethyl-6-(piperazin-1-yl)pyrimidine

ChemComp-K1S:
N,N-diethyl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine / トラピジル / アンタゴニスト*YM

ChemComp-LR9:
3-amino-N-ethyl-N-methylbenzamide

ChemComp-LQV:
(2S)-N-(5-methylpyridin-2-yl)oxolane-2-carboxamide

ChemComp-ZIM:
N-(2-chlorophenyl)-4-(furan-2-carbonyl)piperazine-1-carboxamide

ChemComp-ZJ8:
4-(furan-2-carbonyl)-N-propylpiperazine-1-carboxamide

ChemComp-ZJE:
N-{[(2S)-oxolan-2-yl]methyl}-4-(thiophene-2-carbonyl)piperazine-1-carboxamide

ChemComp-ZJI:
N-cyclopropyl-4-(furan-2-carbonyl)piperazine-1-carboxamide

ChemComp-ZJN:
(3S)-2-benzyl-N'-[4-(furan-2-carbonyl)piperazine-1-carbonyl]-1,2,3,4-tetrahydroisoquinoline-3-carbohydrazide

ChemComp-ZJR:
4-(furan-2-carbonyl)-N-(prop-2-yn-1-yl)piperazine-1-carboxamide

ChemComp-ZJW:
N-[2-(3-ethyl-4H-1,2,4-triazol-4-yl)ethyl]-4-(5-methylthiophene-2-carbonyl)piperazine-1-carboxamide

ChemComp-ZK0:
N-tert-butyl-4-(2,3,3-trimethyl-3H-indole-5-carbonyl)piperazine-1-carboxamide

ChemComp-ZK6:
4-(furan-2-carbonyl)-N-phenylpiperazine-1-carboxamide

ChemComp-ZKC:
tert-butyl [3-({[4-(furan-2-carbonyl)piperazine-1-carbonyl]amino}methyl)phenyl]carbamate

ChemComp-ZKH:
N-(2-methoxyethyl)-4-(thiophene-2-carbonyl)piperazine-1-carboxamide

ChemComp-ZKL:
(2R)-N-butyl-4-(furan-2-carbonyl)-2-methylpiperazine-1-carboxamide

ChemComp-ZKQ:
N-(2-fluorophenyl)-4-(furan-2-carbonyl)piperazine-1-carboxamide

ChemComp-ZKU:
4-(furan-2-carbonyl)-N-(pyridin-2-yl)piperazine-1-carboxamide

ChemComp-ZKZ:
N-methyl-4-[5-(phenoxymethyl)furan-2-carbonyl]piperazine-1-carboxamide

ChemComp-ZL3:
(3R)-4-(furan-2-carbonyl)-3-methyl-N-(propan-2-yl)piperazine-1-carboxamide

ChemComp-ZL8:
4-(3-chlorobenzoyl)-N-[3-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-3-oxopropyl]-1,4-diazepane-1-carboxamide

ChemComp-ZLC:
4-(5-methylfuran-2-carbonyl)-N-[(thiophen-2-yl)methyl]piperazine-1-carboxamide

ChemComp-ZLH:
(2S)-N-(cyclopropylmethyl)-4-(furan-2-carbonyl)-2-methylpiperazine-1-carboxamide

ChemComp-ZLW:
N-(2-aminoethyl)-4-(furan-2-carbonyl)piperazine-1-carboxamide

ChemComp-ZM6:
N-(cyclopropylmethyl)-4-(3,4-dichlorobenzoyl)piperazine-1-carboxamide

ChemComp-ZM0:
4-(thieno[3,2-b]thiophene-2-carbonyl)-N-[(2S)-2,3,3-trimethylbutyl]piperazine-1-carboxamide

ChemComp-ZMN:
4-(5-bromofuran-2-carbonyl)-N-[3-(3-methylphenoxy)propyl]piperazine-1-carboxamide

ChemComp-ZMW:
N-benzyl-4-(furan-2-carbonyl)piperazine-1-carboxamide

ChemComp-ZNX:
N-(4-methoxyphenyl)-4-(5-methylfuran-2-carbonyl)piperazine-1-carboxamide

ChemComp-ZOH:
(2R)-4-(furan-3-carbonyl)-N-(4-methoxyphenyl)-2-methylpiperazine-1-carboxamide

ChemComp-ZO5:
N-[(2H-1,3-benzodioxol-5-yl)methyl]-4-(furan-2-carbonyl)piperazine-1-carboxamide

ChemComp-ZOK:
(2S)-4-(furan-2-carbonyl)-2-methyl-N-(2,2,2-trifluoroethyl)piperazine-1-carboxamide

ChemComp-ZOU:
4-(furan-2-carbonyl)-N-(2-methoxy-5-methylphenyl)piperazine-1-carboxamide

ChemComp-ZP0:
N-{[(2S)-5,5-dimethyl-1,4-dioxan-2-yl]methyl}-4-(3-hydroxybenzoyl)piperazine-1-carboxamide

ChemComp-ZP5:
4-(furan-2-carbonyl)-N-(1,2-oxazol-3-yl)piperazine-1-carboxamide

ChemComp-ZPB:
N-(propan-2-yl)-4-(thiophene-2-carbonyl)piperazine-1-carboxamide

ChemComp-ZPL:
N-[2-(4,5-dimethyl-1,3-thiazol-2-yl)ethyl]-4-(thiophene-2-carbonyl)piperazine-1-carboxamide

ChemComp-ZQ0:
N-butyl-4-(5-methylfuran-2-carbonyl)piperazine-1-carboxamide

ChemComp-ZQ5:
N-butyl-4-(thiophene-2-carbonyl)piperazine-1-carboxamide

ChemComp-ZQ9:
4-(thiophene-2-carbonyl)-N-[(thiophen-2-yl)methyl]piperazine-1-carboxamide

ChemComp-S7A:
3,3,3-tris(fluoranyl)-1-piperazin-1-yl-propan-1-one

ChemComp-ZTQ:
(2S)-2-[([1,1'-biphenyl]-4-yl)oxy]propanoic acid

ChemComp-ZU7:
N-(4-fluorophenyl)-2-(piperazin-1-yl)acetamide

ChemComp-Z3H:
N-[(4R)-3,4-dihydro-2H-1-benzopyran-4-yl]methanesulfonamide

ChemComp-ZUC:
3-fluoro-N-(2-hydroxy-6-methylphenyl)pyridine-4-carboxamide

ChemComp-ZUG:
N,N-dimethylpyridine-3-sulfonamide / N,N-ジメチルピリジン-3-スルホンアミド

ChemComp-ZUW:
1-(2,3-dihydro-1,4-benzoxazepin-4(5H)-yl)ethan-1-one

ChemComp-ZUZ:
methyl N-(cyclohexanecarbonyl)glycinate / [(シクロヘキシルカルボニル)アミノ]酢酸メチル

ChemComp-ZV2:
2-(2-azanyl-1,3-thiazol-3-yl)-~{N}-(4-fluorophenyl)ethanamide

ChemComp-8C2:
N-[(3,5-dimethyl-1H-pyrazol-4-yl)methyl]cyclohexanamine

ChemComp-ZV5:
(5R)-1,3,7-triazaspiro[4.5]decane-2,4-dione

ChemComp-ZV8:
2-tert-butyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine

ChemComp-ZVB:
2-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridine

ChemComp-ZVE:
(3R)-3-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]piperidine

ChemComp-ZVH:
(1S,2R)-2-(thiophen-3-yl)cyclopentane-1-carboxylic acid

ChemComp-YEK:
methyl 1-(methanesulfonyl)-2-methyl-D-prolinate

ChemComp-HV2:
1,1-bis(oxidanylidene)thietan-3-ol / 3-ヒドロキシチエタン1,1-ジオキシド

ChemComp-ZVK:
ethyl N'-(4-ethylphenyl)-N-methylcarbamimidothioate

ChemComp-ZVN:
2-(piperazin-1-yl)-1,3-benzothiazole / 2-ピペラジノベンゾチアゾ-ル

ChemComp-YFR:
6-bromo-7-hydroxy-2,2-dimethyl-2H,4H-1,3-benzodioxin-4-one

ChemComp-ZW5:
1-[(3-fluoro-4-methoxyphenyl)methyl]piperazine


化合物 画像なし

ChemComp-K4R:
Unknown entry


化合物 画像なし

ChemComp-K6U:
Unknown entry

ChemComp-K7L:
(4S)-imidazo[1,2-a]pyrimidine-5,7-diol

ChemComp-EYK:
2-tert-butylbenzene-1,4-diol / tert-ブチルヒドロキノン


化合物 画像なし

ChemComp-KF8:
Unknown entry


化合物 画像なし

ChemComp-K8L:
Unknown entry

ChemComp-GV4:
2-cyano-~{N}-(1,3,5-trimethylpyrazol-4-yl)ethanamide


化合物 画像なし

ChemComp-K96:
Unknown entry


化合物 画像なし

ChemComp-K9N:
Unknown entry


化合物 画像なし

ChemComp-KB3:
Unknown entry


化合物 画像なし

ChemComp-KA3:
Unknown entry

ChemComp-RWP:
methyl 4-[(trifluoroacetyl)amino]benzoate


化合物 画像なし

ChemComp-KCC:
Unknown entry

ChemComp-2NU:
2-(4-bromanylpyrazol-1-yl)-~{N}-cyclopropyl-~{N}-methyl-ethanamide


化合物 画像なし

ChemComp-KBU:
Unknown entry

由来
  • homo sapiens (ヒト)
  • zika virus (ジカ熱ウイルス)
  • porphyromonas gingivalis (バクテリア)
  • severe acute respiratory syndrome coronavirus 2 (ウイルス)
キーワードCELL CYCLE / SGC - Diamond I04-1 fragment screening / PanDDA / XChemExplorer / HYDROLASE / NUDIX domain / TRANSFERASE / macrodomain / NUDT5 / Hydrolase/Transferase / Hydrolase-Transferase complex / TRANSCRIPTION / BROMODOMAIN / BPTF / FALZ / FAC1 / BROMODOMAIN AND PHD FINGER-CONTAINING TRANSCRIPTION FACTOR / FETAL ALZ-50 CLONE 1 PROTEIN / RNA BINDING PROTEIN / CPSF5 / RNA PROCESSING / CLEAVAGE FACTOR / MRNA PROCESSING / NUCLEUS / PHOSPHOPROTEIN / RNA-BINDING / NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 22 / IMMUNE SYSTEM / FIBRINOGEN-RELATED PROTEIN (FREP) / PRO-INFLAMMATORY / DAMAGE-ASSOCIATED MOLECULAR PATTERN (DAMP) / VIRAL PROTEIN / OXIDOREDUCTASE / Diamond I04-1 fragment screening / peptidase / Porphyromonas gingivalis / HYDROLASE/HYDROLASE INHIBITOR / HYDROLASE-HYDROLASE INHIBITOR complex / SIGNALING PROTEIN / False negatives / ligand features / rescreening / catalogue / fragment follow-ups / automated chemistry / STRUCTURAL PROTEIN

+
万見文献について

-
お知らせ

-
2022年2月9日: EMDBエントリの付随情報ファイルのフォーマットが新しくなりました

EMDBエントリの付随情報ファイルのフォーマットが新しくなりました

  • EMDBのヘッダファイルのバージョン3が、公式のフォーマットとなりました。
  • これまでは公式だったバージョン1.9は、アーカイブから削除されます。

関連情報:EMDBヘッダ

外部リンク:wwPDBはEMDBデータモデルのバージョン3へ移行します

-
2020年8月12日: 新型コロナ情報

新型コロナ情報

URL: https://pdbj.org/emnavi/covid19.php

新ページ: EM Navigatorに新型コロナウイルスの特設ページを開設しました。

関連情報:Covid-19情報 / 2020年3月5日: 新型コロナウイルスの構造データ

+
2020年3月5日: 新型コロナウイルスの構造データ

新型コロナウイルスの構造データ

関連情報:万見生物種 / 2020年8月12日: 新型コロナ情報

外部リンク:COVID-19特集ページ - PDBj / 今月の分子2020年2月:コロナウイルスプロテーアーゼ

+
2019年1月31日: EMDBのIDの桁数の変更

EMDBのIDの桁数の変更

  • EMDBエントリに付与されているアクセスコード(EMDB-ID)は4桁の数字(例、EMD-1234)でしたが、間もなく枯渇します。これまでの4桁のID番号は4桁のまま変更されませんが、4桁の数字を使い切った後に発行されるIDは5桁以上の数字(例、EMD-12345)になります。5桁のIDは2019年の春頃から発行される見通しです。
  • EM Navigator/万見では、接頭語「EMD-」は省略されています。

関連情報:Q: 「EMD」とは何ですか? / 万見/EM NavigatorにおけるID/アクセスコードの表記

外部リンク:EMDB Accession Codes are Changing Soon! / PDBjへお問い合わせ

+
2017年7月12日: PDB大規模アップデート

PDB大規模アップデート

  • 新バージョンのPDBx/mmCIF辞書形式に基づくデータがリリースされました。
  • 今回の更新はバージョン番号が4から5になる大規模なもので、全エントリデータの書き換えが行われる「Remediation」というアップデートに該当します。
  • このバージョンアップで、電子顕微鏡の実験手法に関する多くの項目の書式が改定されました(例:em_softwareなど)。
  • EM NavigatorとYorodumiでも、この改定に基づいた表示内容になります。

外部リンク:wwPDB Remediation / OneDepデータ基準に準拠した、より強化された内容のモデル構造ファイルが、PDBアーカイブで公開されました。

-
万見文献

EMDB/PDB/SASBDBから引用されている文献のデータベース

  • EMDB/PDB/SASBDBのエントリから引用されている文献のデータベースです
  • Pubmedのデータを利用しています

関連情報:EMDB / PDB / SASBDB / 万見 (Yorodumi) / EMN文献 / 新しいEM Navigatorと万見の変更点

他の情報も見る